{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T11:53:26Z","timestamp":1794484406232,"version":"4.9.1"},"reference-count":659,"publisher":"Oxford University Press (OUP)","issue":"27","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7,14]]},"DOI":"10.1093\/eurheartj\/ehw128","type":"journal-article","created":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T11:54:52Z","timestamp":1464004492000},"page":"2129-2200","source":"Crossref","is-referenced-by-count":11232,"title":["2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure"],"prefix":"10.1093","volume":"37","author":[{"given":"Piotr","family":"Ponikowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan A","family":"Voors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G F","family":"Cleland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J S","family":"Coats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkmar","family":"Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ram\u00f3n","family":"Gonz\u00e1lez-Juanatey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veli-Pekka","family":"Harjola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa A","family":"Jankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariell","family":"Jessup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Linde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Nihoyannopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T","family":"Parissis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkert","family":"Pieske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian P","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe M C","family":"Rosano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M","family":"Ruilope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Ruschitzka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans H","family":"Rutten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ESC Scientific Document Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos","family":"Filippatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J V","family":"McMurray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Aboyans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Achenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Agewall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawwar","family":"Al-Attar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John James","family":"Atherton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Bauersachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"John Camm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scipione","family":"Carerj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Ceconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Coca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c7etin","family":"Erol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Ezekowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Covadonga","family":"Fern\u00e1ndez-Golf\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Fitzsimons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Guazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Guenoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Hasenfuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Hindricks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno W","family":"Hoes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Iung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiny","family":"Jaarsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulus","family":"Kirchhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhani","family":"Knuuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Kolh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Konstantinides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitja","family":"Lainscak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizio","family":"Lancellotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y H","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Maisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C","family":"Petrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo F","family":"Piepoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia G","family":"Priori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Torbicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Tsutsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk J","family":"van Veldhuisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Windecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clyde","family":"Yancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Zamorano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Zamorano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Aboyans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Achenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Agewall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Badimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Bar\u00f3n-Esquivias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen J","family":"Bax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scipione","family":"Carerj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c7etin","family":"Erol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Fitzsimons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Gaemperli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulus","family":"Kirchhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Kolh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizio","family":"Lancellotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y H","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Nihoyannopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo F","family":"Piepoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Roffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Torbicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3nio","family":"Vaz Carneiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Windecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamayak S","family":"Sisakian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnur","family":"Isayev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Kurlianskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Mullens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya","family":"Tokmakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Agathangelou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vojtech","family":"Melenovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Wiggers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Hassanein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiina","family":"Uuetoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyri","family":"Lommi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeta Srbinovska","family":"Kostovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Juilli\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Aladashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Luchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Chrysohoou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mi","family":"Nyolczas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gestur","family":"Thorgeirsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Marc Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Di Lenarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazipa","family":"Aidargaliyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gani","family":"Bajraktari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medet","family":"Beishenkulov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginta","family":"Kamzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Abdel-Massih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Celutkiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Noppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Cassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Vataman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadia","family":"Abir-Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"van Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rune","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Straburzynska-Migaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e2ndida","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ovidiu","family":"Chioncel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny","family":"Shlyakhto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petar","family":"Otasevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Goncalvesov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitja","family":"Lainscak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"D\u00edaz Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Schaufelberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Suter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Birhan","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid","family":"Voronkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceri","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,5,20]]},"reference":[{"key":"2026080920452718600_EHW128C1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/ejhf.262","article-title":"International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registry","volume":"17","author":"Filippatos","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C2","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"316","author":"The CONSENSUS Trial Study Group","year":"1987","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C3","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1093\/eurheartj\/ehv565","article-title":"Improving outcomes in heart failure: a personal perspective","volume":"36","author":"McMurray","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C4","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1161\/01.CIR.0000085166.44904.79","article-title":"Natural history of asymptomatic left ventricular systolic dysfunction in the community","volume":"108","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C5","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions","volume":"327","author":"The SOLVD Investigators","year":"1992","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jchf.2013.10.006","article-title":"Developing therapies for heart failure with preserved ejection fraction: current state and future directions","volume":"2","author":"Butler","year":"2014","journal-title":"JACC Heart Fail"},{"key":"2026080920452718600_EHW128C7","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C8","first-page":"228","article-title":"Clinical practice","volume":"3623","author":"McMurray","year":"2010","journal-title":"Systolic heart failure. N Engl J Med"},{"key":"2026080920452718600_EHW128C9","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/jama.2011.1474","article-title":"National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998\u20132008","volume":"306","author":"Chen","year":"2011","journal-title":"JAMA"},{"key":"2026080920452718600_EHW128C10","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.jacc.2009.08.019","article-title":"Hospitalizations after heart failure diagnosis a community perspective","volume":"54","author":"Dunlay","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ejheart.2007.04.003","article-title":"Advanced chronic heart failure: a position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology","volume":"9","author":"Metra","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C12","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"2013 ACCF\/AHA Guideline for the Management of Heart Failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C13","first-page":"457","article-title":"Treatment of myocardial infarction in a coronary care unit","volume":"20","author":"Killip","year":"1967","journal-title":"A two year experience with 250 patients. Am J Cardiol"},{"key":"2026080920452718600_EHW128C14","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/hrt.2003.025270","article-title":"Clinical epidemiology of heart failure","volume":"93","author":"Mosterd","year":"2007","journal-title":"Heart"},{"key":"2026080920452718600_EHW128C15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.289.2.194","article-title":"Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic","volume":"289","author":"Redfield","year":"2003","journal-title":"JAMA"},{"key":"2026080920452718600_EHW128C16","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.ehj.2004.06.038","article-title":"Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study","volume":"25","author":"Bleumink","year":"2004","journal-title":"Eur Heart J England;"},{"key":"2026080920452718600_EHW128C17","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1388-9842(02)00034-X","article-title":"Prevalence of chronic heart failure in Southwestern Europe: the EPICA study","volume":"4","author":"Ceia","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C18","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ejhf.110","article-title":"Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion","volume":"16","author":"van Riet","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/eurjhf\/hfr036","article-title":"Heart failure diagnosis and prognosis in the elderly: the proof of the pudding is in the eating","volume":"13","author":"Filippatos","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C20","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/eurheartj\/ehi291","article-title":"Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease","volume":"26","author":"Rutten","year":"2005","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C21","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1007\/s00125-012-2579-0","article-title":"High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes","volume":"55","author":"Boonman-de Winter","year":"2012","journal-title":"Diabetologia"},{"key":"2026080920452718600_EHW128C22","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.483","article-title":"Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review","author":"van Riet","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5694\/j.1326-5377.2006.tb00173.x","article-title":"Prevalence of heart failure and systolic ventricular dysfunction in older Australians: the Canberra Heart Study","volume":"184","author":"Abhayaratna","year":"2006","journal-title":"Med J Aust"},{"key":"2026080920452718600_EHW128C24","doi-asserted-by":"crossref","first-page":"e59225","DOI":"10.1371\/journal.pone.0059225","article-title":"Prevalence of symptomatic heart failure with reduced and with normal ejection fraction in an elderly general population\u2014the CARLA study","volume":"8","author":"Tiller","year":"2013","journal-title":"PLoS One"},{"key":"2026080920452718600_EHW128C25","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/eurjhf\/hfs052","article-title":"Prevalence of preclinical and clinical heart failure in the elderly","volume":"14","author":"Mureddu","year":"2012","journal-title":"A population-based study in Central Italy. Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.echo.2003.11.002","article-title":"Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction","volume":"17","author":"Badano","year":"2004","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080920452718600_EHW128C27","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0002-9343(00)00601-X","article-title":"Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors","volume":"109","author":"Philbin","year":"2000","journal-title":"Am J Med"},{"key":"2026080920452718600_EHW128C28","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.amjcard.2011.06.044","article-title":"Prevalence of heart failure with preserved ejection fraction in Latin American, Middle Eastern, and North African Regions in the I PREFER study (Identification of Patients With Heart Failure and PREserved Systolic Function: an epidemiological regional study","volume":"108","author":"Maga\u00f1a-Serrano","year":"2011","journal-title":"Am J Cardiol"},{"key":"2026080920452718600_EHW128C29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1071-9164(03)00579-7","article-title":"Prevalence and predictors of heart failure with preserved systolic function: community hospital admissions of a racially and gender diverse elderly population","volume":"10","author":"Peyster","year":"2004","journal-title":"J Card Fail"},{"key":"2026080920452718600_EHW128C30","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1067\/mhj.2003.187","article-title":"Heart failure after myocardial infarction: prevalence of preserved left ventricular systolic function in the community","volume":"145","author":"Hellermann","year":"2003","journal-title":"Am Heart J"},{"key":"2026080920452718600_EHW128C31","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jamainternmed.2015.0924","article-title":"A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010","volume":"175","author":"Gerber","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2026080920452718600_EHW128C32","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C33","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/eurheartj\/ehr254","article-title":"The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis","volume":"33","author":"Meta-analysis Global Group in Chronic Heart Failure (MAGGIC)","year":"2012","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C34","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/ejhf.159","article-title":"The middle child in heart failure: heart failure with mid-range ejection fraction (40\u201350%)","volume":"16","author":"Lam","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C35","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/eurjhf\/hft050","article-title":"EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)","volume":"15","author":"Maggioni","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C36","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/eurheartj\/ehs337","article-title":"Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies","volume":"34","author":"Pocock","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C37","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jchf.2014.04.008","article-title":"Risk prediction in patients with heart failure","volume":"2","author":"Rahimi","year":"2014","journal-title":"JACC Heart Fail"},{"key":"2026080920452718600_EHW128C38","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jchf.2014.04.006","article-title":"Factors influencing the predictive power of models for predicting mortality and\/or heart-failure hospitalization in patients with heart failure","volume":"2","author":"Ouwerkerk","year":"2014","journal-title":"JACC Heart Fail"},{"key":"2026080920452718600_EHW128C39","doi-asserted-by":"crossref","first-page":"e85466","DOI":"10.1371\/journal.pone.0085466","article-title":"Development of a novel heart failure risk tool: the Barcelona bio-heart failure risk calculator (BCN bio-HF calculator)","volume":"9","author":"Lup\u00f3n","year":"2014","journal-title":"PLoS One"},{"key":"2026080920452718600_EHW128C40","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","article-title":"The Seattle Heart Failure Model: prediction of survival in heart failure","volume":"113","author":"Levy","year":"2006","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C41","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCULATIONAHA.106.687103","article-title":"Prediction of mode of death in heart failure: the Seattle Heart Failure Model","volume":"116","author":"Mozaffarian","year":"2007","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C42","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/qjmed\/90.5.335","article-title":"Assessing diagnosis in heart failure: which features are any use","volume":"90","author":"Davie","year":"1997","journal-title":"QJM"},{"key":"2026080920452718600_EHW128C43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta13320","article-title":"Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care","volume":"13","author":"Mant","year":"2009","journal-title":"Health Technol Assess"},{"key":"2026080920452718600_EHW128C44","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/eurjhf\/hfr021","article-title":"Clinical evaluation of geriatric outpatients with suspected heart failure: value of symptoms, signs, and additional tests","volume":"13","author":"Oudejans","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10741-006-9481-0","article-title":"Diagnosis of heart failure in primary care","volume":"11","author":"Fonseca","year":"2006","journal-title":"Heart Fail Rev"},{"key":"2026080920452718600_EHW128C46","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1161\/CIRCULATIONAHA.111.019216","article-title":"The diagnostic value of physical examination and additional testing in primary care patients with suspected heart failure","volume":"124","author":"Kelder","year":"2011","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ejhf.216","article-title":"Efficiently screening heart failure in patients with type 2 diabetes","volume":"17","author":"Boonman-de Winter","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C48","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1136\/bmj.38664.661181.55","article-title":"Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study","volume":"331","author":"Rutten","year":"2005","journal-title":"BMJ"},{"key":"2026080920452718600_EHW128C49","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/eurjhf\/hfn013","article-title":"Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology","volume":"11","author":"Hawkins","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C50","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.ahj.2005.10.011","article-title":"How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study","volume":"151","author":"Daniels","year":"2006","journal-title":"Am Heart J"},{"key":"2026080920452718600_EHW128C51","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jacc.2013.05.072","article-title":"Clinical characteristics and outcomes of young and very young adults with heart failure: the CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity)","volume":"62","author":"Wong","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C52","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1093\/eurheartj\/ehu216","article-title":"Heart failure in younger patients: the Meta-analysis Global Group in Chronic Heart Failure (MAGGIC)","volume":"35","author":"Wong","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C53","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jchf.2013.07.009","article-title":"Characterization of a novel symptom of advanced heart failure: bendopnea","volume":"2","author":"Thibodeau","year":"2014","journal-title":"JACC Heart Fail"},{"key":"2026080920452718600_EHW128C54","doi-asserted-by":"crossref","first-page":"h910","DOI":"10.1136\/bmj.h910","article-title":"The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting","volume":"350","author":"Roberts","year":"2015","journal-title":"BMJ"},{"key":"2026080920452718600_EHW128C55","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ejheart.2008.07.014","article-title":"State of the art: using natriuretic peptide levels in clinical practice","volume":"10","author":"Maisel","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C56","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ejheart.2005.01.022","article-title":"The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study","volume":"7","author":"Zaphiriou","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C57","first-page":"327","article-title":"The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure","volume":"56","author":"Fuat","year":"2006","journal-title":"Br J Gen Pract"},{"key":"2026080920452718600_EHW128C58","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1054\/jcaf.2000.9676","article-title":"Clinical criteria and biochemical markers for the detection of systolic dysfunction","volume":"6","author":"Yamamoto","year":"2000","journal-title":"J Card Fail"},{"key":"2026080920452718600_EHW128C59","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0140-6736(97)06031-5","article-title":"Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care","volume":"350","author":"Cowie","year":"1997","journal-title":"Lancet"},{"key":"2026080920452718600_EHW128C60","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0002-9343(01)00841-5","article-title":"Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction","volume":"111","author":"Krishnaswamy","year":"2001","journal-title":"Am J Med"},{"key":"2026080920452718600_EHW128C61","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.cardfail.2011.04.013","article-title":"Clinical utility of three B-type natriuretic peptide assays for the initial diagnostic assessment of new slow-onset heart failure","volume":"17","author":"Kelder","year":"2011","journal-title":"J Card Fail"},{"key":"2026080920452718600_EHW128C62","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ijcard.2014.08.007","article-title":"Obesity and natriuretic peptides, BNP and NT-proBNP: Mechanisms and diagnostic implications for heart failure","volume":"176","author":"Madamanchi","year":"2014","journal-title":"Int J Cardiol"},{"key":"2026080920452718600_EHW128C63","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/bmj.312.7025.222","article-title":"Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction","volume":"312","author":"Davie","year":"1996","journal-title":"BMJ"},{"key":"2026080920452718600_EHW128C64","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0002-9343(02)01048-3","article-title":"Utility of history, physical examination, electrocardiogram, and chest radiograph for differentiating normal from decreased systolic function in patients with heart failure","volume":"112","author":"Thomas","year":"2002","journal-title":"Am J Med"},{"key":"2026080920452718600_EHW128C65","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1093\/eurheartj\/ehm037","article-title":"How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology","volume":"28","author":"Paulus","year":"2007","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C66","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jcmg.2010.02.002","article-title":"Recent developments in heart failure imaging","volume":"3","author":"Marwick","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080920452718600_EHW128C67","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/ejechocard\/jer157","article-title":"Assessment of the American Society of Echocardiography-European Association of Echocardiography guidelines for diastolic function in patients with depressed ejection fraction: an echocardiographic and invasive haemodynamic study","volume":"12","author":"Dokainish","year":"2011","journal-title":"Eur J Echocardiogr"},{"key":"2026080920452718600_EHW128C68","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jacc.2007.03.048","article-title":"Echocardiography in heart failure: applications, utility, and new horizons","volume":"50","author":"Kirkpatrick","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C69","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1161\/CIRCIMAGING.111.963496","article-title":"Echocardiographic evaluation of hemodynamics in patients with decompensated systolic heart failure","volume":"4","author":"Nagueh","year":"2011","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080920452718600_EHW128C70","first-page":"1031","article-title":"Echocardiographic reference ranges for normal cardiac Doppler data: results from the NORRE Study","volume":"16","author":"Caballero","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080920452718600_EHW128C71","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/ehjci\/jeu299","article-title":"Appropriateness criteria for cardiovascular imaging use in heart failure: report of literature review","volume":"16","author":"Garbi","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080920452718600_EHW128C72","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080920452718600_EHW128C73","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1093\/eurheartj\/ehu433","article-title":"Non-invasive cardiac imaging evaluation of patients with chronic systolic heart failure: a report from the European Association of Cardiovascular Imaging (EACVI)","volume":"35","author":"Gimelli","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ehjci\/jeu184","article-title":"Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI\/ASE\/Industry Task Force to standardize deformation imaging","volume":"16","author":"Voigt","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080920452718600_EHW128C75","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1445-5994.2007.01454.x","article-title":"Meta-analysis of B type natriuretic peptide and N-terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction","volume":"38","author":"Ewald","year":"2008","journal-title":"Intern Med J"},{"key":"2026080920452718600_EHW128C76","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1001\/archinte.164.18.1978","article-title":"A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure","volume":"164","author":"Doust","year":"2004","journal-title":"Arch Intern Med"},{"key":"2026080920452718600_EHW128C77","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.cardfail.2005.04.022","article-title":"Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure","volume":"11","author":"Gustafsson","year":"2005","journal-title":"J Card Fail"},{"key":"2026080920452718600_EHW128C78","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/00365510410002878","article-title":"Neuroendocrine testing in community patients with heart disease: plasma N-terminal proatrial natriuretic peptide predicts morbidity and mortality stronger than catecholamines and heart rate variability","volume":"64","author":"Nielsen","year":"2004","journal-title":"Scand J Clin Lab Invest"},{"key":"2026080920452718600_EHW128C79","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.jacc.2015.03.043","article-title":"Patient selection in heart failure with preserved ejection fraction clinical trials","volume":"65","author":"Kelly","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C80","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/0735-1097(96)00088-5","article-title":"A practical guide to assessment of ventricular diastolic function using Doppler echocardiography","volume":"27","author":"Cohen","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C81","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.echo.2006.08.005","article-title":"Diastolic function: a sonographer's approach to the essential echocardiographic measurements of left ventricular diastolic function","volume":"20","author":"Gilman","year":"2007","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080920452718600_EHW128C82","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/ejechocard\/jep007","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography","volume":"10","author":"Nagueh","year":"2009","journal-title":"Eur J Echocardiogr"},{"key":"2026080920452718600_EHW128C83","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0735-1097(96)00315-4","article-title":"Noninvasive doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: a simultaneous Doppler echocardiographic and cardiac catheterization study","volume":"28","author":"Nishimura","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C84","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/01.CIR.102.15.1788","article-title":"Clinical utility of Doppler echocardiography and tissue doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study","volume":"102","author":"Ommen","year":"2000","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C85","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/ejhf.184","article-title":"A systematic review of diastolic stress tests in heart failure with preserved ejection fraction, with proposals from the EU-FP7 MEDIA study group","volume":"16","author":"Erdei","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C86","first-page":"106","article-title":"Value of exercise echocardiography in heart failure with preserved ejection fraction: a substudy from the KaRen study","volume":"17","author":"Donal","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080920452718600_EHW128C87","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/CIRCHEARTFAILURE.109.930701","article-title":"Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction","volume":"3","author":"Borlaug","year":"2010","journal-title":"Circ Heart Fail"},{"key":"2026080920452718600_EHW128C88","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C89","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/ehjci\/jeu128","article-title":"European Association of Cardiovascular Imaging (EACVI) position paper: multimodality imaging in pericardial disease","volume":"16","author":"Cosyns","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080920452718600_EHW128C90","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Caforio","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C91","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11897-015-0261-9","article-title":"Role of imaging techniques for diagnosis, prognosis and management of heart failure patients: cardiac magnetic resonance","volume":"12","author":"Gonzalez","year":"2015","journal-title":"Curr Heart Fail Rep"},{"key":"2026080920452718600_EHW128C92","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/MNM.0000000000000143","article-title":"Nuclear medicine in the management of patients with heart failure: guidance from an expert panel of the International Atomic Energy Agency (IAEA)","volume":"35","author":"Peix","year":"2014","journal-title":"Nucl Med Commun"},{"key":"2026080920452718600_EHW128C93","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1093\/eurheartj\/ehm456","article-title":"The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology","volume":"28","author":"Cooper","year":"2007","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C94","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1093\/eurheartj\/ehq271","article-title":"Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"31","author":"Charron","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C95","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.echo.2011.11.010","article-title":"EAE\/ASE recommendations for image acquisition and display using three-dimensional echocardiography","volume":"25","author":"Lang","year":"2012","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080920452718600_EHW128C96","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","article-title":"Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography. Endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography","volume":"23","author":"Rudski","year":"2010","journal-title":"J Am Soc Echocardiogr"},{"key":"2026080920452718600_EHW128C97","first-page":"ehv317","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"37","author":"Gali\u00e8","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C98","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jacc.2014.01.084","article-title":"Three-dimensional speckle tracking of the right ventricle: toward optimal quantification of right ventricular dysfunction in pulmonary hypertension","volume":"64","author":"Smith","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C99","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/eurheartj\/ehn492","article-title":"Stress Echocardiography Expert Consensus Statement\u2014Executive Summary: European Association of Echocardiography (EAE) (a registered branch of the ESC)","volume":"30","author":"Sicari","year":"2009","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C100","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ejhf.78","article-title":"Usefulness and limitations of contractile reserve evaluation in patients with low-flow, low-gradient aortic stenosis eligible for cardiac resynchronization therapy","volume":"16","author":"Garnier","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C101","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1161\/CIR.0b013e3181d44a8f","article-title":"ACCF\/ACR\/AHA\/NASCI\/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the american college of cardiology foundation task force on expert consensus documents","volume":"121","author":"Hundley","year":"2010","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C102","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/eurheartj\/ehp586","article-title":"Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the respective working groups of the European Society of Cardiology","volume":"31","author":"Kilner","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C103","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1532-429X-15-92","article-title":"Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement","volume":"15","author":"Moon","year":"2013","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026080920452718600_EHW128C104","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/eurjhf\/hfs206","article-title":"Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure","volume":"15","author":"Yoshida","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C105","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jcmg.2015.03.013","article-title":"Severity of remodeling, myocardial viability, and survival in ischemic LV dysfunction after surgical revascularization","volume":"8","author":"Bonow","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026080920452718600_EHW128C106","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/ehf2.12019","article-title":"Predictive power of late gadolinium enhancement for myocardial recovery in chronic ischaemic heart failure: a HEART sub-study","volume":"1","author":"McDiarmid","year":"2014","journal-title":"ESC Heart Fail"},{"key":"2026080920452718600_EHW128C107","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/eurjhf\/hfq230","article-title":"The heart failure revascularisation trial (HEART)","volume":"13","author":"Cleland","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C108","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/RMR.0b013e3182a14e79","article-title":"Safety of magnetic resonance contrast media: a review with special focus on nephrogenic systemic fibrosis","volume":"24","author":"Haneder","year":"2015","journal-title":"Top Magn Reson Imaging"},{"key":"2026080920452718600_EHW128C109","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s12265-011-9290-2","article-title":"SPECT imaging for detecting coronary artery disease and determining prognosis by noninvasive assessment of myocardial perfusion and myocardial viability","volume":"4","author":"Beller","year":"2011","journal-title":"J Cardiovasc Transl Res"},{"key":"2026080920452718600_EHW128C110","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C111","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.jacc.2007.09.006","article-title":"F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2)","volume":"50","author":"Beanlands","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C112","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","article-title":"2014 ESC\/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C113","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease","volume":"34","author":"Montalescot","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C114","article-title":"2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","author":"Roffi","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C115","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.jacc.2015.08.882","article-title":"Importance of angina in patients with coronary disease, heart failure, and left ventricular systolic dysfunction: insights from STICH","volume":"66","author":"Jolic\u0153ur","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C116","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0735-1097(02)01726-6","article-title":"Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis","volume":"39","author":"Allman","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C117","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/CIRCIMAGING.112.000138","article-title":"Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction inducible ischemia versus hibernating myocardium","volume":"6","author":"Ling","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026080920452718600_EHW128C118","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJMoa1100358","article-title":"Myocardial viability and survival in ischemic left ventricular dysfunction","volume":"364","author":"Bonow","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C119","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/ejhf.156","article-title":"Cardiopulmonary exercise testing in systolic heart failure in 2014: the evolving prognostic role: a position paper from the committee on exercise physiology and training of the heart failure association of the ESC","volume":"16","author":"Corr\u00e0","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C120","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/eurjhf\/hfr017","article-title":"Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation","volume":"13","author":"Piepoli","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C121","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00134-012-2513-4","article-title":"International evidence-based recommendations for point-of-care lung ultrasound","volume":"38","author":"Volpicelli","year":"2012","journal-title":"Intensive Care Med"},{"key":"2026080920452718600_EHW128C122","first-page":"195","article-title":"Genetics of hypertrophic cardiomyopathy: advances and pitfalls in molecular diagnosis and therapy","volume":"7","author":"Roma-Rodrigues","year":"2014","journal-title":"Appl Clin Genet"},{"key":"2026080920452718600_EHW128C123","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1172\/JCI62862","article-title":"Genetic mutations and mechanisms in dilated cardiomyopathy","volume":"123","author":"McNally","year":"2013","journal-title":"J Clin Invest"},{"key":"2026080920452718600_EHW128C124","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"key":"2026080920452718600_EHW128C125","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jacc.2014.05.027","article-title":"The MOGE(S) classification of cardiomyopathy for clinicians","volume":"64","author":"Arbustini","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C126","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/jama.1997.03550030052033","article-title":"Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension","volume":"278","author":"Kostis","year":"1997","journal-title":"JAMA"},{"key":"2026080920452718600_EHW128C127","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C128","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/archinternmed.2010.427","article-title":"Antihypertensive treatment and development of heart failure in hypertension","volume":"171","author":"Sciarretta","year":"2011","journal-title":"Arch Intern Med"},{"key":"2026080920452718600_EHW128C129","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C130","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C131","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0735-1097(01)01195-0","article-title":"Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction","volume":"37","author":"Suskin","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C132","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/CIRCHEARTFAILURE.114.001787","article-title":"Alcohol and incident heart failure among middle-aged and elderly men: the cohort of Swedish men","volume":"8","author":"Dorans","year":"2015","journal-title":"Circ Heart Fail"},{"key":"2026080920452718600_EHW128C133","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/eurheartj\/ehu514","article-title":"Alcohol consumption and risk of heart failure: the Atherosclerosis Risk in Communities Study","volume":"36","author":"Goncalves","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C134","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ejhf.228","article-title":"Alcohol consumption and risk of heart failure: a dose-response meta-analysis of prospective studies","volume":"17","author":"Larsson","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C135","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1161\/CIRCULATIONAHA.115.015853","article-title":"Dose-response relationship between physical activity and risk of heart failure: a meta-analysis","volume":"132","author":"Pandey","year":"2015","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C136","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jama.2013.7588","article-title":"Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial","volume":"310","author":"Ledwidge","year":"2013","journal-title":"JAMA"},{"key":"2026080920452718600_EHW128C137","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/j.jacc.2006.03.034","article-title":"Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study","volume":"47","author":"Scirica","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C138","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/hrt.2006.112508","article-title":"Intensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative meta-analysis of randomised controlled trials","volume":"93","author":"Afilalo","year":"2007","journal-title":"Heart"},{"key":"2026080920452718600_EHW128C139","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1071-9164(97)90022-1","article-title":"The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease","volume":"3","author":"Kjekshus","year":"1997","journal-title":"J Card Fail"},{"key":"2026080920452718600_EHW128C140","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jacc.2006.08.052","article-title":"N-terminal pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC\/BHF Heart Protection Study","volume":"49","author":"Protection","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C141","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa020245","article-title":"Obesity and the risk of heart failure","volume":"347","author":"Kenchaiah","year":"2002","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C142","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(06)69201-5","article-title":"Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials","volume":"368","author":"Dagenais","year":"2006","journal-title":"Lancet"},{"key":"2026080920452718600_EHW128C143","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jacc.2013.05.069","article-title":"PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial","volume":"62","author":"Huelsmann","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C144","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(03)13501-5","article-title":"Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study","volume":"361","author":"Jong","year":"2003","journal-title":"Lancet"},{"key":"2026080920452718600_EHW128C145","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C146","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"key":"2026080920452718600_EHW128C147","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1093\/eurheartj\/ehu164","article-title":"Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study","volume":"35","author":"Montalescot","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C148","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C149","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C150","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C151","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/archinternmed.2010.427","article-title":"Antihypertensive treatment and development of heart failure in hypertension: a Bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk","volume":"171","author":"Sciarretta","year":"2011","journal-title":"Arch Intern Med"},{"key":"2026080920452718600_EHW128C152","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/eurheartj\/ehv072","article-title":"The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials","volume":"36","author":"Preiss","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C153","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S2213-8587(15)00044-3","article-title":"Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials","volume":"3","author":"Udell","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026080920452718600_EHW128C154","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/ijo.2013.203","article-title":"The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data","volume":"38","author":"Padwal","year":"2014","journal-title":"Int J Obes"},{"key":"2026080920452718600_EHW128C155","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/CIRCULATIONAHA.106.661405","article-title":"Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk","volume":"115","author":"Held","year":"2007","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C156","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1001\/jama.292.23.2874","article-title":"Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials","volume":"292","author":"Desai","year":"2004","journal-title":"JAMA"},{"key":"2026080920452718600_EHW128C157","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C158","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa041489","article-title":"Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction","volume":"351","author":"Hohnloser","year":"2004","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C159","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1388-9842(01)00198-2","article-title":"The current cost of heart failure to the National Health Service in the UK","volume":"4","author":"Stewart","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C160","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.hfc.2013.05.002","article-title":"Recognizing hospitalized heart failure as an entity and developing new therapies to improve outcomes: academics\u2019, clinicians\u2019, industry's, regulators\u2019, and payers\u2019 perspectives","volume":"9","author":"Gheorghiade","year":"2013","journal-title":"Heart Fail Clin"},{"key":"2026080920452718600_EHW128C161","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","article-title":"The global health and economic burden of hospitalizations for heart failure","volume":"63","author":"Ambrosy","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C162","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C163","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","article-title":"Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure","volume":"273","author":"Garg","year":"1995","journal-title":"JAMA"},{"key":"2026080920452718600_EHW128C164","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1161\/01.CIR.100.23.2312","article-title":"Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure","volume":"100","author":"Packer","year":"1999","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C165","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"SOLVD Investigattors","year":"1991","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C166","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/eurjhf\/hft134","article-title":"Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry","volume":"15","author":"Maggioni","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C167","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jama.283.10.1295","article-title":"MERIT-HF Study Group. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR\/XL Randomized Intervention Trial in congestive Heart Failure (MERIT-HF)","volume":"283","author":"Hjalmarson","year":"2000","journal-title":"JAMA"},{"key":"2026080920452718600_EHW128C168","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C169","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure","volume":"334","author":"Packer","year":"1996","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C170","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"2026080920452718600_EHW128C171","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/01.CIR.0000035653.72855.BF","article-title":"Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study","volume":"106","author":"Packer","year":"2002","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C172","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","author":"CIBIS-II Investigators and Committees","year":"1999","journal-title":"Lancet"},{"key":"2026080920452718600_EHW128C173","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/eurheartj\/ehi115","article-title":"Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)","volume":"26","author":"Flather","year":"2005","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C174","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C176","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.105.582320","article-title":"Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III","volume":"112","author":"Willenheimer","year":"2005","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C177","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(14)61373-8","article-title":"Efficacy of \u03b2 blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis","volume":"384","author":"Kotecha","year":"2014","journal-title":"Lancet"},{"key":"2026080920452718600_EHW128C178","first-page":"CD003838","article-title":"Diuretics for heart failure","volume":"2","author":"Faris","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080920452718600_EHW128C179","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0167-5273(01)00600-3","article-title":"Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials","volume":"82","author":"Faris","year":"2002","journal-title":"Int J Cardiol"},{"key":"2026080920452718600_EHW128C180","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"2026080920452718600_EHW128C181","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.jacc.2012.01.020","article-title":"Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study","volume":"59","author":"Swedberg","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C182","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial","volume":"362","author":"Granger","year":"2003","journal-title":"Lancet"},{"key":"2026080920452718600_EHW128C183","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa042934","article-title":"Combination of isosorbide dinitrate and hydralazine in blacks with heart failure","volume":"351","author":"Taylor","year":"2004","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C184","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJM198606123142404","article-title":"Effect of vasodilator therapy on mortality in chronic congestive heart failure","volume":"314","author":"Cohn","year":"1986","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C185","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","author":"Digitalis Investigation Group","year":"1997","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C186","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(08)61239-8","article-title":"Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Tavazzi","year":"2008","journal-title":"Lancet"},{"key":"2026080920452718600_EHW128C187","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/phar.1629","article-title":"Neprilysin inhibition in heart failure with reduced ejection fraction: a clinical review","volume":"35","author":"King","year":"2015","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"key":"2026080920452718600_EHW128C188","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/eurheartj\/ehs262","article-title":"Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics","volume":"34","author":"Mangiafico","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C189","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/eurheartj\/ehv015","article-title":"Neprilysin, cardiovascular, and Alzheimer's diseases: the therapeutic split","volume":"36","author":"Vodovar","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C190","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0006-8993(01)03008-6","article-title":"Relationship between beta amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain","volume":"919","author":"Yasojima","year":"2001","journal-title":"Brain Res"},{"key":"2026080920452718600_EHW128C191","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1136\/jnnp.2008.160002","article-title":"Combined risk effects of IDE and NEP gene variants on Alzheimer disease","volume":"80","author":"Vepsalainen","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026080920452718600_EHW128C192","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12861","article-title":"The effect of LCZ696 on amyloid-\u03b2 concentrations in cerebrospinal fluid in healthy subjects","author":"Langenickel","journal-title":"Br J Clin Pharmacol"},{"key":"2026080920452718600_EHW128C193","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00392-012-0467-8","article-title":"Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study","volume":"102","author":"B\u00f6hm","year":"2013","journal-title":"Clin Res Cardiol"},{"key":"2026080920452718600_EHW128C194","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C195","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.amjcard.2015.01.013","article-title":"Meta-analysis of digoxin use and risk of mortality in patients with atrial fibrillation","volume":"115","author":"Ouyang","year":"2015","journal-title":"Am J Cardiol"},{"key":"2026080920452718600_EHW128C196","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/eurheartj\/ehv143","article-title":"Digoxin-associated mortality: a systematic review and meta-analysis of the literature","volume":"36","author":"Vamos","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C197","doi-asserted-by":"crossref","first-page":"h4451","DOI":"10.1136\/bmj.h4451","article-title":"Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data","volume":"351","author":"Ziff","year":"2015","journal-title":"BMJ"},{"key":"2026080920452718600_EHW128C198","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","article-title":"Lenient versus strict rate control in patients with atrial fibrillation","volume":"362","author":"Van Gelder","year":"2010","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C199","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijcard.2015.04.031","article-title":"Digoxin in patients with atrial fibrillation and heart failure: a meta-analysis","volume":"188","author":"Bavishi","year":"2015","journal-title":"Int J Cardiol"},{"key":"2026080920452718600_EHW128C200","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/CIRCEP.114.002292","article-title":"Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN Study","volume":"8","author":"Freeman","year":"2015","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"2026080920452718600_EHW128C201","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1016\/S0140-6736(14)61836-5","article-title":"Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)","volume":"385","author":"Washam","year":"2015","journal-title":"Lancet"},{"key":"2026080920452718600_EHW128C202","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/eurjhf\/hft093","article-title":"Lenient vs. strict rate control in patients with atrial fibrillation and heart failure: a post-hoc analysis of the RACE II study","volume":"15","author":"Mulder","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C203","first-page":"13","article-title":"Do omega-3 polyunsaturated fatty acids prevent cardiovascular disease? A review of the randomized clinical trials","volume":"6","author":"Lucas","year":"2013","journal-title":"Lipid Insights"},{"key":"2026080920452718600_EHW128C204","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"Reiner","year":"2011","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C205","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1056\/NEJMoa0706201","article-title":"Rosuvastatin in older patients with systolic heart failure","volume":"357","author":"Kjekshus","year":"2007","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C206","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1056\/NEJMoa1202299","article-title":"Warfarin and aspirin in patients with heart failure and sinus rhythm","volume":"366","author":"Homma","year":"2012","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C207","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/eurjhf\/hfs073","article-title":"Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis","volume":"14","author":"Lip","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C208","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/jama.2013.1954","article-title":"Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial","volume":"309","author":"Gheorghiade","year":"2013","journal-title":"JAMA"},{"key":"2026080920452718600_EHW128C209","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/11587580-000000000-00000","article-title":"Thiazolidinediones and risk of heart failure in patients with or at high risk of type 2 diabetes mellitus: a meta-analysis and meta-regression analysis of placebo-controlled randomized clinical trials","volume":"11","author":"Hernandez","year":"2011","journal-title":"Am J Cardiovasc Drugs"},{"key":"2026080920452718600_EHW128C210","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/eurheartj\/ehp604","article-title":"Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial","volume":"31","author":"Komajda","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C211","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/S0140-6736(04)16299-5","article-title":"Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study","volume":"363","author":"Mamdani","year":"2004","journal-title":"Lancet"},{"key":"2026080920452718600_EHW128C212","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1136\/hrt.2005.082388","article-title":"Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population","volume":"92","author":"Huerta","year":"2006","journal-title":"Heart"},{"key":"2026080920452718600_EHW128C213","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ejheart.2008.07.013","article-title":"Non-steroidal anti-inflammatory drugs and cardiac failure: meta-analyses of observational studies and randomised controlled trials","volume":"10","author":"Scott","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C214","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/01.CIR.83.1.52","article-title":"Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee and the Multicenter Diltiazem Postinfarction Research Group","volume":"83","author":"Goldstein","year":"1991","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C215","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1056\/NEJM199610103351504","article-title":"Effect of amlodipine on morbidity and mortality in severe chronic heart failure","volume":"335","author":"Packer","year":"1996","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C216","first-page":"856","article-title":"Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III","volume":"96","author":"Cohn","year":"1997","journal-title":"Vasodilator-Heart Failure Trial (V-HeFT) Study Group. Circulation"},{"key":"2026080920452718600_EHW128C217","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jchf.2015.02.006","article-title":"Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction","volume":"3","author":"Abraham","year":"2015","journal-title":"JACC Heart Fail"},{"key":"2026080920452718600_EHW128C218","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/eurheartj\/ehu345","article-title":"Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial","volume":"36","author":"Zannad","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C219","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/eurheartj\/ehr298","article-title":"Transvenous phrenic nerve stimulation for the treatment of central sleep apnoea in heart failure","volume":"33","author":"Ponikowski","year":"2012","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C220","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jchf.2014.12.013","article-title":"Phrenic nerve stimulation for the treatment of central sleep apnea","volume":"3","author":"Abraham","year":"2015","journal-title":"JACC Heart Fail"},{"key":"2026080920452718600_EHW128C221","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ahj.2010.10.025","article-title":"A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure","volume":"161","author":"Kadish","year":"2011","journal-title":"Am Heart J"},{"key":"2026080920452718600_EHW128C222","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/eurheartj\/ehn020","article-title":"Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure","volume":"29","author":"Borggrefe","year":"2008","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C223","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJM199711273372202","article-title":"A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators","volume":"337","author":"Wyse","year":"1997","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C224","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1053\/euhj.2000.2476","article-title":"Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study","volume":"21","author":"Connolly","year":"2000","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C225","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1161\/01.CIR.101.11.1297","article-title":"Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone","volume":"101","author":"Connolly","year":"2000","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C226","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.CIR.102.7.748","article-title":"Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH)","volume":"102","author":"Kuck","year":"2000","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C227","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter\u2013defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C228","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1056\/NEJMoa0901889","article-title":"Defibrillator implantation early after myocardial infarction","volume":"361","author":"Steinbeck","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C229","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJMsa051989","article-title":"Cost-effectiveness of implantable cardioverter-defibrillators","volume":"353","author":"Sanders","year":"2005","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C230","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jchf.2014.06.007","article-title":"Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials","volume":"2","author":"Steinberg","year":"2014","journal-title":"JACC Heart Fail"},{"key":"2026080920452718600_EHW128C231","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/eurheartj\/ehv102","article-title":"The effect of duration of follow-up and presence of competing risk on lifespan-gain from implantable cardioverter defibrillator therapy: who benefits the most","volume":"36","author":"Raphael","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C232","first-page":"792","article-title":"Baseline functional class and therapeutic efficacy of common heart failure interventions: a systematic review and meta-analysis","volume":"31","author":"Miller","year":"2015","journal-title":"Can J Cardiol"},{"key":"2026080920452718600_EHW128C233","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1161\/CIRCOUTCOMES.114.001306","article-title":"Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials","volume":"8","author":"Hess","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026080920452718600_EHW128C234","doi-asserted-by":"crossref","first-page":"e001289","DOI":"10.1161\/JAHA.114.001289","article-title":"Incidence of defibrillator shocks after elective generator exchange following uneventful first battery life","volume":"3","author":"Merchant","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"2026080920452718600_EHW128C235","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1136\/heartjnl-2014-305535","article-title":"Evaluation of the need of elective implantable cardioverter-defibrillator generator replacement in primary prevention patients without prior appropriate ICD therapy","volume":"100","author":"Yap","year":"2014","journal-title":"Heart"},{"key":"2026080920452718600_EHW128C236","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.jacc.2014.03.025","article-title":"Appropriateness of primary prevention implantable cardioverter-defibrillators at the time of generator replacement: are indications still met","volume":"63","author":"Kini","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C237","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/eurheartj\/ehs177","article-title":"Long-term benefit of implantable cardioverter\/defibrillator therapy after elective device replacement: Results of the INcidence free SUrvival after ICD REplacement (INSURE) trial\u2014a prospective multicentre study","volume":"34","author":"Erkapic","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C238","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1540-8167.2008.01111.x","article-title":"Time-dependence of appropriate implantable defibrillator therapy in patients with ischemic cardiomyopathy","volume":"19","author":"Alsheikh-Ali","year":"2008","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080920452718600_EHW128C239","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.healun.2015.04.004","article-title":"Wearable cardioverter-defibrillator as a bridge to cardiac transplantation: a national database analysis","volume":"34","author":"Opreanu","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"2026080920452718600_EHW128C240","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/CIRCEP.112.973552","article-title":"Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator","volume":"6","author":"Zishiri","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080920452718600_EHW128C241","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jacc.2010.04.016","article-title":"Aggregate national experience with the wearable cardioverter-defibrillator","volume":"56","author":"Chung","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C242","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(97)05281-1","article-title":"Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators","volume":"350","year":"1997","journal-title":"Lancet"},{"key":"2026080920452718600_EHW128C243","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijcard.2010.05.012","article-title":"Mortality of newly diagnosed heart failure treated with amiodarone: a propensity-matched study","volume":"151","author":"Andrey","year":"2011","journal-title":"Int J Cardiol"},{"key":"2026080920452718600_EHW128C244","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.cardfail.2007.02.009","article-title":"The safety of amiodarone in patients with heart failure","volume":"13","author":"Torp-Pedersen","year":"2007","journal-title":"J Card Fail"},{"key":"2026080920452718600_EHW128C245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-5273(98)00184-3","article-title":"Overview and meta-analysis of randomised trials of amiodarone in chronic heart failure","volume":"66","author":"Piepoli","year":"1998","journal-title":"Int J Cardiol"},{"key":"2026080920452718600_EHW128C246","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.amjcard.2012.04.034","article-title":"Meta-analysis of cardiovascular outcomes with dronedarone in patients with atrial fibrillation or heart failure","volume":"110","author":"Chatterjee","year":"2012","journal-title":"Am J Cardiol"},{"key":"2026080920452718600_EHW128C247","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1056\/NEJMoa0800456","article-title":"Increased mortality after dronedarone therapy for severe heart failure","volume":"358","author":"K\u00f8ber","year":"2008","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C248","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial","volume":"324","author":"Echt","year":"1991","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C249","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/europace\/euq329","article-title":"Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis","volume":"12","author":"Theuns","year":"2010","journal-title":"Europace"},{"key":"2026080920452718600_EHW128C250","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-150-11-200906020-00007","article-title":"Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures","volume":"150","author":"Cook","year":"2009","journal-title":"Ann Intern Med"},{"key":"2026080920452718600_EHW128C251","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","article-title":"Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators","volume":"335","author":"Moss","year":"1996","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C252","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C253","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2013.4598","article-title":"Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial","volume":"309","author":"Gasparini","year":"2013","journal-title":"JAMA"},{"key":"2026080920452718600_EHW128C254","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nrcardio.2009.233","article-title":"Device therapy: defibrillators\u2014a shocking therapy for cardiomyopathy","volume":"7","author":"Cleland","year":"2010","journal-title":"Nat Rev Cardiol"},{"key":"2026080920452718600_EHW128C255","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cardfail.2009.09.003","article-title":"Patient expectations from implantable defibrillators to prevent death in heart failure","volume":"16","author":"Stewart","year":"2010","journal-title":"J Card Fail"},{"key":"2026080920452718600_EHW128C256","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa0909545","article-title":"An entirely subcutaneous implantable cardioverter-defibrillator","volume":"363","author":"Bardy","year":"2010","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C257","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.jacc.2014.01.018","article-title":"The subcutaneous defibrillator","volume":"63","author":"Aziz","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C258","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ahj.2012.02.012","article-title":"Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy","volume":"163","author":"Olde Nordkamp","year":"2012","journal-title":"Am Heart J"},{"key":"2026080920452718600_EHW128C259","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.jacc.2015.02.047","article-title":"Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE Study and EFFORTLESS Registry","volume":"65","author":"Burke","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C260","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the Europe","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C261","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJM200103223441202","article-title":"Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay","volume":"344","author":"Cazeau","year":"2001","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C262","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C263","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/eurheartj\/ehl099","article-title":"Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C264","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/eurjhf\/hfs055","article-title":"Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization\u2013Heart Failure (CARE-HF) trial","volume":"14","author":"Cleland","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C265","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C266","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1093\/eurheartj\/eht290","article-title":"An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure","volume":"34","author":"Cleland","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C267","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1009540","article-title":"Cardiac-resynchronization therapy for mild-to-moderate heart failure","volume":"363","author":"Tang","year":"2010","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C268","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","article-title":"Cardiac-resynchronization therapy for the prevention of heart-failure events","volume":"361","author":"Moss","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C269","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1056\/NEJMoa1401426","article-title":"Survival with cardiac-resynchronization therapy in mild heart failure","volume":"370","author":"Goldenberg","year":"2014","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C270","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2008.08.027","article-title":"Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms","volume":"52","author":"Linde","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C271","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.jacc.2009.08.011","article-title":"Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE trial","volume":"54","author":"Daubert","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C272","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1093\/eurheartj\/eht160","article-title":"Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study","volume":"34","author":"Linde","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C273","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1136\/heartjnl-2015-307634","article-title":"Individual patient data network meta-analysis of mortality effects of implantable cardiac devices","volume":"101","author":"Woods","year":"2015","journal-title":"Heart"},{"key":"2026080920452718600_EHW128C274","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJMoa1210356","article-title":"Biventricular pacing for atrioventricular block and systolic dysfunction","volume":"368","author":"Curtis","year":"2013","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C275","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1093\/eurheartj\/ehr162","article-title":"Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial","volume":"32","author":"Brignole","year":"2011","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C276","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1053\/euhj.2002.3232","article-title":"Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation","volume":"23","author":"Leclercq","year":"2002","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C277","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/europace\/eus193","article-title":"Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis","volume":"14","author":"Stavrakis","year":"2012","journal-title":"Europace"},{"key":"2026080920452718600_EHW128C278","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/hrt.2010.207340","article-title":"Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial","volume":"97","author":"MacDonald","year":"2011","journal-title":"Heart"},{"key":"2026080920452718600_EHW128C279","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.jacc.2013.01.069","article-title":"A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure","volume":"61","author":"Jones","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C280","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jacc.2008.06.043","article-title":"Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies","volume":"52","author":"Upadhyay","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C281","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jchf.2013.06.003","article-title":"Cardiac resynchronization therapy in patients with atrial fibrillation. The CERTIFY Study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry)","volume":"1","author":"Gasparini","year":"2013","journal-title":"JACC Heart Fail"},{"key":"2026080920452718600_EHW128C282","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/ejhf.143","article-title":"Echocardiographic and clinical response to cardiac resynchronization therapy in heart failure patients with and without previous right ventricular pacing","volume":"16","author":"Gage","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C283","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1306687","article-title":"Cardiac-resynchronization therapy in heart failure with a narrow QRS complex","volume":"369","author":"Ruschitzka","year":"2013","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C284","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1093\/eurheartj\/ehv242","article-title":"The effect of QRS duration on cardiac resynchronization therapy in patients with a narrow QRS complex: a subgroup analysis of the EchoCRT trial","volume":"36","author":"Steffel","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C285","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jamainternmed.2014.2717","article-title":"Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data","volume":"174","author":"Zusterzeel","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2026080920452718600_EHW128C286","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jchf.2014.11.007","article-title":"Opportunity to increase life span in narrow QRS cardiac resynchronization therapy recipients by deactivating ventricular pacing: evidence from randomized controlled trials","volume":"3","author":"Sohaib","year":"2015","journal-title":"JACC Heart Fail"},{"key":"2026080920452718600_EHW128C287","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ahj.2008.11.006","article-title":"Effects of cardiac resynchronization therapy on long-term quality of life: an analysis from the Cardiac Resynchronisation-Heart Failure (CARE-HF) study","volume":"157","author":"Cleland","year":"2009","journal-title":"Am Heart J"},{"key":"2026080920452718600_EHW128C288","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/eurheartj\/ehv264","article-title":"Reflections on EchoCRT: sound guidance on QRS duration and morphology for CRT?","volume":"36","author":"Cleland","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C289","first-page":"424","article-title":"Gender, underutilization of cardiac resynchronization therapy, and prognostic impact of QRS prolongation and left bundle branch block in heart failure","volume-title":"Europace","author":"Linde","year":"2015"},{"key":"2026080920452718600_EHW128C290","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/j.1540-8167.2005.50062.x","article-title":"Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study)","volume":"16","author":"Doshi","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080920452718600_EHW128C291","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/europace\/eut343","article-title":"Characteristics of a large sample of candidates for permanent ventricular pacing included in the Biventricular Pacing for Atrio-ventricular Block to Prevent Cardiac Desynchronization Study (BioPace)","volume":"16","author":"Funck","year":"2014","journal-title":"Europace"},{"key":"2026080920452718600_EHW128C292","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1161\/CIRCULATIONAHA.107.743120","article-title":"Results of the Predictors of Response to CRT (PROSPECT) Trial","volume":"117","author":"Chung","year":"2008","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C293","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/eurheartj\/ehn577","article-title":"The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial","volume":"30","author":"Wikstrom","year":"2009","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C294","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.jacc.2011.12.030","article-title":"Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial","volume":"59","author":"Khan","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C295","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/CIRCHEARTFAILURE.112.000078","article-title":"Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy: results of the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region Trial","volume":"6","author":"Saba","year":"2013","journal-title":"Circ Heart Fail"},{"key":"2026080920452718600_EHW128C296","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.amjcard.2013.12.006","article-title":"Meta-analysis of effects of optimization of cardiac resynchronization therapy on left ventricular function, exercise capacity, and quality of life in patients with heart failure","volume":"113","author":"Kosmala","year":"2014","journal-title":"Am J Cardiol"},{"key":"2026080920452718600_EHW128C297","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1016\/j.ijcard.2013.01.216","article-title":"Comparison of different invasive hemodynamic methods for AV delay optimization in patients with cardiac resynchronization therapy: Implications for clinical trial design and clinical practice","volume":"168","author":"Whinnett","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026080920452718600_EHW128C298","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/europace\/eut311","article-title":"New devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association","volume":"16","author":"Kuck","year":"2014","journal-title":"Europace"},{"key":"2026080920452718600_EHW128C299","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/eurheartj\/eht436","article-title":"Non-pharmacological modulation of the autonomic tone to treat heart failure","volume":"35","author":"Singh","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C300","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0140-6736(12)61227-6","article-title":"The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial","volume":"380","author":"Solomon","year":"2012","journal-title":"Lancet"},{"key":"2026080920452718600_EHW128C301","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C302","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.2013.2024","article-title":"Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial","volume":"309","author":"Redfield","year":"2013","journal-title":"JAMA"},{"key":"2026080920452718600_EHW128C303","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1093\/eurheartj\/ehu204","article-title":"New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes","volume":"35","author":"Senni","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C304","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/ejhf.304","article-title":"Heart failure with preserved ejection fraction: uncertainties and dilemmas","volume":"17","author":"Ferrari","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C305","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jacc.2011.11.040","article-title":"Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction","volume":"59","author":"Ather","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C306","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCHEARTFAILURE.107.743146","article-title":"Death in heart failure: a community perspective","volume":"1","author":"Henkel","year":"2008","journal-title":"Circ Heart Fail"},{"key":"2026080920452718600_EHW128C307","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/2047487314564729","article-title":"Effects of drug and exercise intervention on functional capacity and quality of life in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials","volume":"23","author":"Fukuta","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"2026080920452718600_EHW128C308","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejheart.2006.10.012","article-title":"Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM","volume":"9","author":"Lewis","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C309","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C310","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"2026080920452718600_EHW128C311","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The perindopril in elderly people with chronic heart failure (PEP-CHF) study","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C312","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/eurjhf\/hfs100","article-title":"Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation: insights from SENIORS","volume":"14","author":"Mulder","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C313","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.jacc.2009.02.046","article-title":"Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction","volume":"53","author":"van Veldhuisen","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C314","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1161\/CIRCULATIONAHA.106.628347","article-title":"Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial","volume":"114","author":"Ahmed","year":"2006","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C315","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial","volume":"362","author":"McMurray","year":"2003","journal-title":"Lancet"},{"key":"2026080920452718600_EHW128C316","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","author":"Kirchof","year":"2016","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C317","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C318","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/eurheartj\/ehu504","article-title":"Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial","volume":"36","author":"Sakata","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C319","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","article-title":"ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"34","author":"Ryd\u00e9n","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C320","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0140-6736(14)61402-1","article-title":"Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy","volume":"385","author":"Gilbert","year":"2015","journal-title":"Lancet"},{"key":"2026080920452718600_EHW128C321","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.jacc.2011.06.054","article-title":"Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction","volume":"58","author":"Edelmann","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C322","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pcad.2013.07.005","article-title":"Prognostic significance of ambulatory ECG monitoring for ventricular arrhythmias","volume":"56","author":"Katritsis","year":"2013","journal-title":"Prog Cardiovasc Dis"},{"key":"2026080920452718600_EHW128C323","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.amjcard.2012.03.021","article-title":"Usefulness of continuous electrocardiographic monitoring for atrial fibrillation","volume":"110","author":"Camm","year":"2012","journal-title":"Am J Cardiol"},{"key":"2026080920452718600_EHW128C324","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/clc.22387","article-title":"Feasibility of extended ambulatory electrocardiogram monitoring to identify silent atrial fibrillation in high-risk patients: the Screening Study for Undiagnosed Atrial Fibrillation (STUDY-AF)","volume":"38","author":"Turakhia","year":"2015","journal-title":"Clin Cardiol"},{"key":"2026080920452718600_EHW128C325","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"Camm","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C326","first-page":"368","article-title":"Sleep apnea and nocturnal cardiac arrhythmia: a populational study","volume":"103","author":"Cintra","year":"2014","journal-title":"Arq Bras Cardiol"},{"key":"2026080920452718600_EHW128C327","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1097\/MD.0000000000000045","article-title":"Obstructive sleep apnea and cardiovascular comorbidities: a large epidemiologic study","volume":"93","author":"Gilat","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"2026080920452718600_EHW128C328","article-title":"Obstructive sleep apnoea\u2013hypopnoea and arrhythmias","author":"Vizzardi","year":"2014","journal-title":"J Cardiovasc Med"},{"key":"2026080920452718600_EHW128C329","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1161\/CIRCULATIONAHA.109.902148","article-title":"Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: the Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) study","volume":"122","author":"Bloch Thomsen","year":"2010","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C330","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0002-9149(00)01450-8","article-title":"Mechanisms and immediate outcome of in-hospital cardiac arrest in patients with advanced heart failure secondary to ischemic or idiopathic dilated cardiomyopathy","volume":"87","author":"Faggiano","year":"2001","journal-title":"Am J Cardiol"},{"key":"2026080920452718600_EHW128C331","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/eurjhf\/hfs097","article-title":"The importance of whether atrial fibrillation or heart failure develops first","volume":"14","author":"Smit","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C332","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/eurheartj\/ehi166","article-title":"Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET","volume":"26","author":"Swedberg","year":"2005","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C333","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/CIRCULATIONAHA.106.614560","article-title":"Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure","volume":"114","author":"Hoppe","year":"2006","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C334","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1016\/j.ijcard.2013.07.017","article-title":"Impact of atrial fibrillation-induced tachycardiomyopathy in patients undergoing pulmonary vein isolation","volume":"168","author":"Calvo","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026080920452718600_EHW128C335","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/postgradmedj-2011-130698","article-title":"Reversible heart failure: toxins, tachycardiomyopathy and mitochondrial abnormalities","volume":"88","author":"Morris","year":"2012","journal-title":"Postgrad Med J"},{"key":"2026080920452718600_EHW128C336","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/01.CIR.100.4.376","article-title":"Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction","volume":"100","author":"Pedersen","year":"1999","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C337","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ahj.2005.06.036","article-title":"Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program","volume":"152","author":"Ducharme","year":"2006","journal-title":"Am Heart J"},{"key":"2026080920452718600_EHW128C338","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jacc.2004.09.076","article-title":"Antiarrhythmic effect of carvedilol after acute myocardial infarction","volume":"45","author":"McMurray","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C339","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jacc.2011.11.063","article-title":"Eplerenone and atrial fibrillation in mild systolic heart failure","volume":"59","author":"Swedberg","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C340","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/FJC.0b013e3182a094a1","article-title":"Renin\u2013angiotensin system inhibitors prevent the recurrence of atrial fibrillation","volume":"62","author":"Han","year":"2013","journal-title":"J Cardiovasc Pharmacol"},{"key":"2026080920452718600_EHW128C341","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1136\/heartjnl-2014-305482","article-title":"Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials","volume":"100","author":"Martin","year":"2014","journal-title":"Heart"},{"key":"2026080920452718600_EHW128C342","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s11886-012-0330-6","article-title":"Is cardiac resynchronization therapy an antiarrhythmic therapy for atrial fibrillation? A systematic review and meta-analysis","volume":"15","author":"Hess","year":"2013","journal-title":"Curr Cardiol Rep"},{"key":"2026080920452718600_EHW128C343","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0002-9149(87)90307-9","article-title":"Amiodarone for maintenance of sinus rhythm after conversion of atrial fibrillation in the setting of a dilated left atrium","volume":"60","author":"Brodsky","year":"1987","journal-title":"Am J Cardiol"},{"key":"2026080920452718600_EHW128C344","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1161\/01.CIR.98.23.2574","article-title":"Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators","volume":"98","author":"Deedwania","year":"1998","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C345","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/hrt.2008.158931","article-title":"A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study)","volume":"95","author":"Shelton","year":"2009","journal-title":"Heart"},{"key":"2026080920452718600_EHW128C346","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1053\/euhj.1999.1734","article-title":"Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation","volume":"21","author":"Capucci","year":"2000","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C347","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMoa1109867","article-title":"Dronedarone in high-risk permanent atrial fibrillation","volume":"365","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C348","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijcard.2005.06.048","article-title":"Effects of a high dose intravenous bolus amiodarone in patients with atrial fibrillation and a rapid ventricular rate","volume":"110","author":"Hofmann","year":"2006","journal-title":"Int J Cardiol"},{"key":"2026080920452718600_EHW128C349","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/heart.84.6.635","article-title":"Intravenous amiodarone bolus immediately controls heart rate in patients with atrial fibrillation accompanied by severe congestive heart failure","volume":"84","author":"Hofmann","year":"2000","journal-title":"Heart"},{"key":"2026080920452718600_EHW128C350","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/CIRCHEARTFAILURE.115.002285","article-title":"Prognostic significance of resting heart rate and use of \u03b2-blockers in atrial fibrillation and sinus rhythm in patients with heart failure and reduced ejection fraction: findings from the Swedish Heart Failure Registry","volume":"8","author":"Li","year":"2015","journal-title":"Circ Heart Fail"},{"key":"2026080920452718600_EHW128C351","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.clinthera.2015.08.017","article-title":"Should \u03b2-blockers be used in patients with heart failure and atrial fibrillation","volume":"37","author":"Mareev","year":"2015","journal-title":"Clin Ther"},{"key":"2026080920452718600_EHW128C352","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.ahj.2004.11.030","article-title":"Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: results from the RAte Control versus Electrical cardioversion (RACE) study","volume":"149","author":"Hagens","year":"2005","journal-title":"Am Heart J"},{"key":"2026080920452718600_EHW128C353","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa021375","article-title":"A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation","volume":"347","author":"Van Gelder","year":"2002","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C354","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/europace\/eul106","article-title":"Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies","volume":"8","author":"Van Gelder","year":"2006","journal-title":"Europace"},{"key":"2026080920452718600_EHW128C355","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1016\/j.jacc.2015.04.045","article-title":"Digoxin use and subsequent outcomes among patients in a contemporary atrial fibrillation cohort","volume":"65","author":"Allen","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C356","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/eurheartj\/eht120","article-title":"Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial","volume":"34","author":"Gheorghiade","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C357","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jacc.2014.03.060","article-title":"Increased mortality associated with digoxin in contemporary patients with atrial fibrillation","volume":"64","author":"Turakhia","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C358","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.jacc.2003.07.020","article-title":"Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?","volume":"42","author":"Khand","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C359","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa0708789","article-title":"Rhythm control versus rate control for atrial fibrillation and heart failure","volume":"358","author":"Roy","year":"2008","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C360","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJMoa0708234","article-title":"Pulmonary-vein isolation for atrial fibrillation in patients with heart failure","volume":"359","author":"Khan","year":"2008","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C361","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.hlc.2014.09.012","article-title":"Catheter ablation of atrial fibrillation in patients with concomitant left ventricular impairment: a systematic review of efficacy and effect on ejection fraction","volume":"24","author":"Ganesan","year":"2015","journal-title":"Heart Lung Circ"},{"key":"2026080920452718600_EHW128C362","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1540-8159.2009.02428.x","article-title":"Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation (CASTLE-AF) \u2013 study design","volume":"32","author":"Marrouche","year":"2009","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026080920452718600_EHW128C363","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1161\/CIRCEP.114.001853","article-title":"Catheter ablation and antiarrhythmic drug therapy as first- or second-line therapy in the management of atrial fibrillation: systematic review and meta-analysis","volume":"7","author":"Khan","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080920452718600_EHW128C364","first-page":"CD005049","article-title":"Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation","volume":"5","author":"Lafuente-Lafuente","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080920452718600_EHW128C365","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/oxfordjournals.eurheartj.a060345","article-title":"A multicentre, randomized trial on the benefit\/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Antiarrhythmic Drug Evaluation Group (A.D.E.G.)","volume":"13","year":"1992","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C366","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"2026080920452718600_EHW128C367","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/ejhf.343","article-title":"Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials","volume":"17","author":"Xiong","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C368","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ijcard.2014.11.101","article-title":"Risk of major bleeding in different indications for new oral anticoagulants: insights from a meta-analysis of approved dosages from 50 randomized trials","volume":"179","author":"Sardar","year":"2015","journal-title":"Int J Cardiol"},{"key":"2026080920452718600_EHW128C369","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/jgs.12799","article-title":"New oral anticoagulants in elderly adults: evidence from a meta-analysis of randomized trials","volume":"62","author":"Sardar","year":"2014","journal-title":"J Am Geriatr Soc"},{"key":"2026080920452718600_EHW128C370","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/europace\/euv309","article-title":"Updated European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation","volume":"17","author":"Heidbuchel","year":"2015","journal-title":"Europace"},{"key":"2026080920452718600_EHW128C371","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C372","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C373","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C374","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C375","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C376","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"2026080920452718600_EHW128C377","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS BLED) to asses 1-year risk of major bleeding in patients with atrial fibrillation","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest J"},{"key":"2026080920452718600_EHW128C378","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMc1007378","article-title":"Newly identified events in the RE-LY trial","volume":"363","author":"Connolly","year":"2010","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C379","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"2026080920452718600_EHW128C380","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C381","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.jacc.2015.04.025","article-title":"Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation: a patient-level meta-analysis","volume":"65","author":"Holmes","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C382","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jcin.2015.08.035","article-title":"Bleeding outcomes after left atrial appendage closure compared with long-term warfarin: a pooled, patient-level analysis of the WATCHMAN randomized trial experience","volume":"8","author":"Price","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"2026080920452718600_EHW128C383","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1388-9842(99)00009-4","article-title":"Sudden death in heart failure: vascular or electrical","volume":"1","author":"Cleland","year":"1999","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C384","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1093\/eurheartj\/ehv186","article-title":"Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients","volume":"36","author":"Desai","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C385","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-artery bypass surgery in patients with left ventricular dysfunction","volume":"364","author":"Velazquez","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C386","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.jacc.2013.02.014","article-title":"Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction","volume":"61","author":"Panza","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C387","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jchf.2013.04.012","article-title":"The STICH trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death results","volume":"1","author":"Carson","year":"2013","journal-title":"JACC Heart Fail"},{"key":"2026080920452718600_EHW128C388","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00001573-200401000-00007","article-title":"Subanalyses of secondary prevention implantable cardioverter-defibrillator trials: antiarrhythmics versus implantable defibrillators (AVID), Canadian Implantable Defibrillator Study (CIDS), and Cardiac Arrest Study Hamburg (CASH)","volume":"19","author":"Oseroff","year":"2004","journal-title":"Curr Opin Cardiol"},{"key":"2026080920452718600_EHW128C389","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/eurheartj\/eht150","article-title":"2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association","volume":"34","author":"Brignole","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C390","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.archger.2010.02.010","article-title":"Diagnostic and prognostic value of brain natriuretic peptide (BNP) concentrations in very elderly heart disease patients: specific geriatric cut-off and impacts of age, gender, renal dysfunction, and nutritional status","volume":"52","author":"Blond\u00e9-Cynober","year":"2011","journal-title":"Arch Gerontol Geriatr"},{"key":"2026080920452718600_EHW128C391","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1093\/eurheartj\/eht192","article-title":"Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services","volume":"34","author":"Hawkins","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C392","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijcard.2014.03.169","article-title":"Iron deficiency and health-related quality of life in chronic heart failure: results from a multicenter European study","volume":"174","author":"Enjuanes","year":"2014","journal-title":"Int J Cardiol"},{"key":"2026080920452718600_EHW128C393","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0735-1097(03)00947-1","article-title":"Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure","volume":"42","author":"Braunstein","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C394","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ahj.2010.05.007","article-title":"Predictors of early readmission or death in elderly patients with heart failure","volume":"160","author":"Muzzarelli","year":"2010","journal-title":"Am Heart J"},{"key":"2026080920452718600_EHW128C395","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1183\/13993003.00853-2015","article-title":"A summary of the new GINA strategy: a roadmap to asthma control","volume":"46","author":"Reddel","year":"2015","journal-title":"Eur Respir J"},{"key":"2026080920452718600_EHW128C396"},{"key":"2026080920452718600_EHW128C397","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/eurjhf\/hfq213","article-title":"Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"13","author":"Eschenhagen","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C398","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C399","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa1406430","article-title":"Ivabradine in stable coronary artery disease without clinical heart failure","volume":"371","author":"Fox","year":"2014","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C400","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijcard.2006.08.082","article-title":"Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease","volume":"120","author":"Marazzi","year":"2007","journal-title":"Int J Cardiol"},{"key":"2026080920452718600_EHW128C401","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ijcard.2012.11.001","article-title":"Efficacy of trimetazidine on functional capacity in symptomatic patients with stable exertional angina\u2014the VASCO-angina study","volume":"168","author":"Vitale","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026080920452718600_EHW128C402","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.ehj.2004.06.034","article-title":"Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease","volume":"25","author":"Vitale","year":"2004","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C403","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/hrt.2010.208751","article-title":"Trimetazidine: a meta-analysis of randomised controlled trials in heart failure","volume":"97","author":"Gao","year":"2011","journal-title":"Heart"},{"key":"2026080920452718600_EHW128C404","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/CIRCULATIONAHA.108.778019","article-title":"Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy","volume":"118","author":"Tuunanen","year":"2008","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C405","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s12325-009-0024-7","article-title":"Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy","volume":"26","author":"Marazzi","year":"2009","journal-title":"Adv Ther"},{"key":"2026080920452718600_EHW128C406","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1475-2840-2-16","article-title":"Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study","volume":"2","author":"Rosano","year":"2003","journal-title":"Cardiovasc Diabetol"},{"key":"2026080920452718600_EHW128C407","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0002-8703(03)00171-6","article-title":"Neurohormones and oxidative stress in nonischemic cardiomyopathy: Relationship to survival and the effect of treatment with amlodipine","volume":"146","author":"Wijeysundera","year":"2003","journal-title":"Am Heart J"},{"key":"2026080920452718600_EHW128C408","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(02)08265-X","article-title":"Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial","volume":"359","author":"IONA Study Group","year":"2002","journal-title":"Lancet"},{"key":"2026080920452718600_EHW128C409","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJM199108013250502","article-title":"A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure","volume":"325","author":"Cohn","year":"1991","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C410","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(08)61170-8","article-title":"Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"key":"2026080920452718600_EHW128C411","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1093\/eurheartj\/ehp358","article-title":"Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial","volume":"30","author":"Fox","year":"2009","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C412","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/CIRCINTERVENTIONS.112.970954","article-title":"Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials","volume":"5","author":"Pursnani","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"2026080920452718600_EHW128C413","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(09)60319-6","article-title":"Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis","volume":"373","author":"Trikalinos","year":"2009","journal-title":"Lancet"},{"key":"2026080920452718600_EHW128C414","first-page":"261","article-title":"Prevalence, incidence and clinical impact of cachexia: facts and numbers\u2014update 2014","volume-title":"J Cachexia Sarcopenia Muscle","author":"von Haehling","year":"2014"},{"key":"2026080920452718600_EHW128C415","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pharmthera.2008.09.009","article-title":"Cardiac cachexia: a systematic overview","volume":"121","author":"von Haehling","year":"2009","journal-title":"Pharmacol Ther"},{"key":"2026080920452718600_EHW128C416","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr"},{"key":"2026080920452718600_EHW128C417","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF02696650","article-title":"Cachexia in chronic heart failure: prognostic implications and novel therapeutic approaches","volume":"2","author":"Akashi","year":"2005","journal-title":"Curr Heart Fail Rep"},{"key":"2026080920452718600_EHW128C418","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/01.CIR.96.2.526","article-title":"Hormonal changes and catabolic\/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia","volume":"96","author":"Anker","year":"1997","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C419","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/eurheartj\/ehs381","article-title":"Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF)","volume":"34","author":"F\u00fclster","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C420","first-page":"253","article-title":"Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014","volume-title":"J Cachexia Sarcopenia Muscle","author":"Morley","year":"2014"},{"key":"2026080920452718600_EHW128C421","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.jamda.2014.09.007","article-title":"Treatment of cachexia: an overview of recent developments","volume":"15","author":"von Haehling","year":"2014","journal-title":"J Am Med Dir Assoc"},{"key":"2026080920452718600_EHW128C422","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/sj.bjc.6604909","article-title":"Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring","volume":"100","author":"Jones","year":"2009","journal-title":"Br J Cancer"},{"key":"2026080920452718600_EHW128C423","first-page":"CD003917","article-title":"Cardioprotective interventions for cancer patients receiving anthracyclines","volume":"6","author":"van Dalen","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080920452718600_EHW128C424","doi-asserted-by":"crossref","first-page":"e000472","DOI":"10.1161\/JAHA.113.000472","article-title":"Risk prediction model for heart failure and cardiomyopathy after adjuvant trastuzumab therapy for breast cancer","volume":"3","author":"Ezaz","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"2026080920452718600_EHW128C425","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/eurheartj\/ehs181","article-title":"Cancer drugs and the heart: Importance and management","volume":"34","author":"Suter","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C426","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 Position paper on anticancer treatments and cardiovascular toxicity","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C427","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1388-9842(00)00119-7","article-title":"Autonomic dysfunction in patients with mild heart failure and coronary artery disease and the effects of add-on beta-blockade","volume":"3","author":"Tjeerdsma","year":"2001","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C428","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ypmed.2014.03.007","article-title":"Depression after heart failure and risk of cardiovascular and all-cause mortality: a meta-analysis","volume":"63","author":"Fan","year":"2014","journal-title":"Prev Med"},{"key":"2026080920452718600_EHW128C429","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.ijcard.2012.03.143","article-title":"Depression, antidepressants, and long-term mortality in heart failure","volume":"167","author":"Diez-Quevedo","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026080920452718600_EHW128C430","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.hfc.2013.10.004","article-title":"Heart failure and depression","volume":"10","author":"Newhouse","year":"2014","journal-title":"Heart Fail Clin"},{"key":"2026080920452718600_EHW128C431","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jad.2015.05.056","article-title":"Validity of beck depression inventory for the assessment of depressive mood in chronic heart failure Patients","volume":"184","author":"Lahlou-Lafor\u00eat","year":"2015","journal-title":"J Affect Disord"},{"key":"2026080920452718600_EHW128C432","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1477-7525-10-141","article-title":"Cardiac Depression Scale: Mokken scaling in heart failure patients","volume":"10","author":"Ski","year":"2012","journal-title":"Health Qual Life Outcomes"},{"key":"2026080920452718600_EHW128C433","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ejhf.101","article-title":"Effects of exercise training on depression in patients with heart failure: a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Tu","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C434","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jama.2012.8720","article-title":"Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial","volume":"308","author":"Blumenthal","year":"2012","journal-title":"JAMA"},{"key":"2026080920452718600_EHW128C435","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jacc.2010.03.068","article-title":"Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial","volume":"56","author":"O'Connor","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C436","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1001\/jama.292.18.2227","article-title":"Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial","volume":"292","author":"Bakris","year":"2004","journal-title":"JAMA"},{"key":"2026080920452718600_EHW128C437","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jacc.2009.04.049","article-title":"Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes","volume":"54","author":"Aguilar","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C438","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1001\/archinte.168.15.1699","article-title":"The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program","volume":"168","author":"Gerstein","year":"2008","journal-title":"Arch Intern Med"},{"key":"2026080920452718600_EHW128C439","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1136\/hrt.2008.156646","article-title":"Elevated glycated haemoglobin is a strong predictor of mortality in patients with left ventricular systolic dysfunction who are not receiving treatment for diabetes mellitus","volume":"95","author":"Goode","year":"2009","journal-title":"Heart"},{"key":"2026080920452718600_EHW128C440","first-page":"1213","article-title":"Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K","volume":"33","author":"MacDonald","year":"2010","journal-title":"General Practice Research Database. Diabetes Care"},{"key":"2026080920452718600_EHW128C441","doi-asserted-by":"crossref","first-page":"e1001204","DOI":"10.1371\/journal.pmed.1001204","article-title":"Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials","volume":"9","author":"Boussageon","year":"2012","journal-title":"PLoS Med"},{"key":"2026080920452718600_EHW128C442","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.numecd.2014.01.017","article-title":"Dipeptidyl peptidase-4 inhibitors and heart failure: a meta-analysis of randomized clinical trials","volume":"24","author":"Monami","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2026080920452718600_EHW128C443","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijcard.2014.12.017","article-title":"Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in diabetic patients: a meta-analysis","volume":"181","author":"Savarese","year":"2015","journal-title":"Int J Cardiol"},{"key":"2026080920452718600_EHW128C444","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2174\/1871530311313010015","article-title":"Managing erectile dysfunction in heart failure","volume":"13","author":"Giagulli","year":"2013","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"2026080920452718600_EHW128C445","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/eurheartj\/eht112","article-title":"Erectile dysfunction in the cardiovascular patient","volume":"34","author":"Vlachopoulos","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C446","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/CIRCHEARTFAILURE.110.944694","article-title":"PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study","volume":"4","author":"Guazzi","year":"2011","journal-title":"Circ Heart Fail"},{"key":"2026080920452718600_EHW128C447","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12916-014-0185-3","article-title":"Is chronic inhibition of phosphodiesterase type 5 cardioprotective and safe? A meta-analysis of randomized controlled trials","volume":"12","author":"Giannetta","year":"2014","journal-title":"BMC Med"},{"key":"2026080920452718600_EHW128C448","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/01.CIR.0000065637.10517.A0","article-title":"Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging","volume":"107","author":"Anker","year":"2003","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C449","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","article-title":"EULAR evidence-based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2026080920452718600_EHW128C450","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.08.089"},{"key":"2026080920452718600_EHW128C451","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s11897-009-0037-1","article-title":"Hyperkalemia in patients with heart failure: incidence, prevalence, and management","volume":"6","author":"Desai","year":"2009","journal-title":"Curr Heart Fail Rep"},{"key":"2026080920452718600_EHW128C452","first-page":"CD003235","article-title":"Emergency interventions for hyperkalaemia","volume":"2","author":"Mahoney","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080920452718600_EHW128C453","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1411487","article-title":"Sodium zirconium cyclosilicate in hyperkalemia","volume":"372","author":"Packham","year":"2015","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C454","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1410853","article-title":"Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors","volume":"372","author":"Weir","year":"2015","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C455","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/ejhf.300","article-title":"Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial","volume":"17","author":"Anker","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C456","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/ejhf.402","article-title":"Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors","volume":"17","author":"Pitt","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C457","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(08)61240-4","article-title":"Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Tavazzi","year":"2008","journal-title":"Lancet"},{"key":"2026080920452718600_EHW128C458","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1001\/jama.283.15.1967","article-title":"Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone. ALLHAT Collaborative Research Group","volume":"283","year":"2000","journal-title":"JAMA"},{"key":"2026080920452718600_EHW128C459","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1007\/s00392-015-0878-4","article-title":"Blood pressure and prognosis in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study","volume":"104","author":"Lip","year":"2015","journal-title":"Clin Res Cardiol"},{"key":"2026080920452718600_EHW128C460","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1388-9842(03)00163-6","article-title":"Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON)","volume":"5","author":"Cohn","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C461","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/S0735-1097(02)02304-5","article-title":"Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors","volume":"40","author":"Maggioni","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C462","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/eurheartj\/ehq502","article-title":"Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial","volume":"32","author":"Pitt","year":"2011","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C463","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure","volume":"334","author":"Packer","year":"1996","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C464","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1071-9164(97)90040-3","article-title":"Vasodilation by urapidil in the treatment of chronic congestive heart failure in addition to angiotensin-converting enzyme inhibitors is not beneficial: results of a placebo-controlled, double-blind study","volume":"3","author":"Dorszewski","year":"1997","journal-title":"J Card Fail"},{"key":"2026080920452718600_EHW128C465","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1136\/bmj.290.6485.1861","article-title":"Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin","volume":"290","author":"Bayliss","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2026080920452718600_EHW128C466","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/eurheartj\/ehs224","article-title":"Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives","volume":"34","author":"Jankowska","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C467","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1093\/eurheartj\/ehu235","article-title":"Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure","volume":"35","author":"Jankowska","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C468","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/eurheartj\/ehs377","article-title":"Iron status in patients with chronic heart failure","volume":"34","author":"Jankowska","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C469","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C470","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C471","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/eurjhf\/hft099","article-title":"Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial","volume":"15","author":"Filippatos","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C472","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.473"},{"key":"2026080920452718600_EHW128C473","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1056\/NEJMoa1506459","article-title":"Adaptive servo-ventilation for central sleep apnea in systolic heart failure","volume":"373","author":"Angermann","year":"2015","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C474","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/CIRCHEARTFAILURE.114.001100","article-title":"Heart failure with anemia: novel findings on the roles of renal disease, interleukins, and specific left ventricular remodeling processes","volume":"7","author":"O'Meara","year":"2014","journal-title":"Circ Heart Fail"},{"key":"2026080920452718600_EHW128C475","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa1214865","article-title":"Treatment of anemia with darbepoetin alfa in systolic heart failure","volume":"368","author":"Swedberg","year":"2013","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C476","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","article-title":"Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis","volume":"35","author":"Damman","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C477","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/eurheartj\/eht515","article-title":"Renal dysfunction and heart failure: things are seldom what they seem","volume":"35","author":"Filippatos","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C478","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJMra1214243","article-title":"Acute kidney injury and chronic kidney disease as interconnected syndromes","volume":"371","author":"Chawla","year":"2014","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C479","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/eurheartj\/ehv010","article-title":"The kidney in heart failure: an update","volume":"36","author":"Damman","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C480","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ejhf.13","article-title":"Worsening renal function during renin-angiotensin-aldosterone system inhibitor initiation and long-term outcomes in patients with left ventricular systolic dysfunction","volume":"16","author":"Clark","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C481","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.ijcard.2012.12.083","article-title":"Airway obstruction in systolic heart failure \u2013 COPD or congestion?","volume":"168","author":"Brenner","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026080920452718600_EHW128C482","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ejhf.183","article-title":"Chronic obstructive pulmonary disease in heart failure: accurate diagnosis and treatment","volume":"16","author":"G\u00fcder","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C483","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","article-title":"European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice","volume":"33","author":"Perk","year":"2012","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C484","first-page":"319","article-title":"The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care","volume":"27","author":"McKelvie","year":"2011","journal-title":"Can J Cardiol"},{"key":"2026080920452718600_EHW128C485","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/eurheartj\/ehu522","article-title":"Sleep disordered breathing and post-discharge mortality in patients with acute heart failure","volume":"36","author":"Khayat","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C486","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s00392-014-0774-3","article-title":"Impact of sleep-disordered breathing and efficacy of positive airway pressure on mortality in patients with chronic heart failure and sleep-disordered breathing: a meta-analysis","volume":"104","author":"Nakamura","year":"2015","journal-title":"Clin Res Cardiol"},{"key":"2026080920452718600_EHW128C487","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCULATIONAHA.109.901801","article-title":"Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the Sleep Heart Health Study","volume":"122","author":"Gottlieb","year":"2010","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C488","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1164\/rccm.2312014","article-title":"Vascular dysfunction in sleep apnea","volume":"169","author":"Imadojemu","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920452718600_EHW128C489","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1378\/chest.11-2089","article-title":"Long-term auto-servoventilation or constant positive pressure in heart failure and coexisting central with obstructive sleep apnea","volume":"142","author":"Randerath","year":"2012","journal-title":"Chest"},{"key":"2026080920452718600_EHW128C490","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1164\/rccm.201205-0894OC","article-title":"Differing effects of obstructive and central sleep apneas on stroke volume in patients with heart failure","volume":"187","author":"Yumino","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026080920452718600_EHW128C491","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa051001","article-title":"Continuous positive airway pressure for central sleep apnea and heart failure","volume":"353","author":"Bradley","year":"2005","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C492","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.cardfail.2015.08.344","article-title":"Design of the remed\u0113 System Pivotal Trial: a prospective, randomized study in the use of respiratory rhythm management to treat central sleep apnea","volume":"21","author":"Costanzo","year":"2015","journal-title":"J Card Fail"},{"key":"2026080920452718600_EHW128C493","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/eurheartj\/ehs109","article-title":"Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"33","author":"Vahanian","year":"2012","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C494","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1016\/j.jacc.2014.02.537","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Nishimura","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C495","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","article-title":"Transcatheter versus surgical aortic-valve replacement in high-risk patients","volume":"364","author":"Smith","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C496","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","article-title":"Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery","volume":"363","author":"Leon","year":"2010","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C497","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jacc.2015.05.017","article-title":"2-Year outcomes in patients undergoing surgical or self-expanding transcatheter aortic valve replacement","volume":"66","author":"Reardon","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C498","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1400590","article-title":"Transcatheter aortic-valve replacement with a self-expanding prosthesis","volume":"370","author":"Adams","year":"2014","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C499","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/ehjci\/jet105","article-title":"Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging","volume":"14","author":"Lancellotti","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026080920452718600_EHW128C500","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1161\/01.CIR.0000038498.59829.38","article-title":"Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function","volume":"106","author":"Chaliki","year":"2002","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C501","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1056\/NEJMoa1410490","article-title":"Surgical treatment of moderate ischemic mitral regurgitation","volume":"371","author":"Smith","year":"2014","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C502","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1312808","article-title":"Mitral-valve repair versus replacement for severe ischemic mitral regurgitation","volume":"370","author":"Acker","year":"2014","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C503","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/eurheartj\/ehv322","article-title":"Surgical and interventional management of mitral valve regurgitation: a position statement from the European Society of Cardiology Working Groups on Cardiovascular Surgery and Valvular Heart Disease","volume":"37","author":"De Bonis","year":"2016","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C504","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.amjcard.2015.04.025","article-title":"Meta-analysis of the usefulness of mitraclip in patients with functional mitral regurgitation","volume":"116","author":"D'ascenzo","year":"2015","journal-title":"Am J Cardiol"},{"key":"2026080920452718600_EHW128C505","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2014.06.1166","article-title":"Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011\u20132012 pilot European Sentinel Registry","volume":"64","author":"Nickenig","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C506","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/eurheartj\/ehv627","article-title":"One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry","volume":"37","author":"Puls","year":"2016","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C507","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0016-5085(83)90198-1","article-title":"Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system","volume":"84","author":"Perez-Ayuso","year":"1983","journal-title":"Gastroenterology"},{"key":"2026080920452718600_EHW128C508","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.jacc.2015.01.025","article-title":"First-in-human transcatheter tricuspid valve repair in a patient with severely regurgitant tricuspid valve","volume":"65","author":"Schofer","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C509","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1161\/CIRCULATIONAHA.112.001290","article-title":"Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis: a Placement of Aortic Transcatheter Valves (PARTNER) trial analysis","volume":"127","author":"Herrmann","year":"2013","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C510","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.recesp.2015.01.003","article-title":"Pathogenesis and clinical presentation of acute heart failure","volume":"68","author":"Ponikowski","year":"2015","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"2026080920452718600_EHW128C511","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijcard.2010.04.003","article-title":"Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy","volume":"144","author":"Metra","year":"2010","journal-title":"Int J Cardiol"},{"key":"2026080920452718600_EHW128C512","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10741-007-9008-3","article-title":"An introduction to acute heart failure syndromes: definition and classification","volume":"12","author":"Filippatos","year":"2007","journal-title":"Heart Fail Rev"},{"key":"2026080920452718600_EHW128C513","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10741-007-9009-2","article-title":"Epidemiology of acute heart failure syndromes","volume":"12","author":"Alla","year":"2007","journal-title":"Heart Fail Rev"},{"key":"2026080920452718600_EHW128C514","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0735-1097(03)00309-7","article-title":"Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure","volume":"41","author":"Nohria","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C515","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ejheart.2005.01.004","article-title":"Design of therapy for advanced heart failure","volume":"7","author":"Stevenson","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C516","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jacc.2008.05.010","article-title":"Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis","volume":"52","author":"Maisel","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C517","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1751-7133.2009.00112.x","article-title":"Early vasoactive drugs improve heart failure outcomes","volume":"15","author":"Peacock","journal-title":"Congest Heart Fail"},{"key":"2026080920452718600_EHW128C518","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0196-0644(05)82777-5","article-title":"Effects of prehospital medications on mortality and length of stay in congestive heart failure","volume":"21","author":"Wuerz","year":"1992","journal-title":"Ann Emerg Med"},{"key":"2026080920452718600_EHW128C519","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0002-9343(91)80016-F","article-title":"Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care","volume":"90","author":"Chakko","year":"1991","journal-title":"Am J Med"},{"key":"2026080920452718600_EHW128C520","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1001\/jama.294.15.1944","article-title":"Does this dyspneic patient in the emergency department have congestive heart failure?","volume":"294","author":"Wang","year":"2005","journal-title":"JAMA"},{"key":"2026080920452718600_EHW128C521","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1136\/hrt.2010.220426","article-title":"Quantifying the added value of BNP in suspected heart failure in general practice: an individual patient data meta-analysis","volume":"97","author":"Kelder","year":"2011","journal-title":"Heart"},{"key":"2026080920452718600_EHW128C522","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1253\/circj.CJ-15-0589","article-title":"Natriuretic peptides and cardiometabolic health","volume":"79","author":"Gupta","year":"2015","journal-title":"Circ J"},{"key":"2026080920452718600_EHW128C523","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nrcardio.2014.64","article-title":"Natriuretic peptides in cardiometabolic regulation and disease","volume":"11","author":"Zois","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"2026080920452718600_EHW128C524","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jjcc.2011.01.002","article-title":"Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides","volume":"57","author":"Nishikimi","year":"2011","journal-title":"J Cardiol"},{"key":"2026080920452718600_EHW128C525","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/ejhf.341","article-title":"Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study","volume":"17","author":"Felker","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C526","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1093\/eurheartj\/ehu283","article-title":"2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism","volume":"35","author":"Konstantinides","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C527","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/eurjhf\/hfr177","article-title":"Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial","volume":"14","author":"Maisel","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C528","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cardfail.2009.08.002","article-title":"Abnormal liver function in relation to hemodynamic profile in heart failure patients","volume":"16","author":"van Deursen","year":"2010","journal-title":"J Card Fail"},{"key":"2026080920452718600_EHW128C529","doi-asserted-by":"crossref","first-page":"471","DOI":"10.20452\/pamw.1413","article-title":"Liver function tests in patients with acute heart failure","volume":"122","author":"Biegus","year":"2012","journal-title":"Pol Arch Med Wewne\u0328trznej"},{"key":"2026080920452718600_EHW128C530","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/eurheartj\/ehs332","article-title":"Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure","volume":"34","author":"Nikolaou","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C531","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1161\/CIRCULATIONAHA.106.666255","article-title":"N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study","volume":"115","author":"Moe","year":"2007","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C532","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.jacc.2010.02.025","article-title":"Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea","volume":"55","author":"Maisel","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C533","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1056\/NEJMoa031681","article-title":"Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea","volume":"350","author":"Mueller","year":"2004","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C534","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMoa020233","article-title":"Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure","volume":"347","author":"Krishnaswamy","year":"2002","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C535","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"33","author":"Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)","year":"2012","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C536","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.annemergmed.2007.02.022","article-title":"Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis","volume":"50","author":"Levy","year":"2007","journal-title":"Ann Emerg Med"},{"key":"2026080920452718600_EHW128C537","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(97)08417-1","article-title":"Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema","volume":"351","author":"Cotter","year":"1998","journal-title":"Lancet"},{"key":"2026080920452718600_EHW128C538","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCOUTCOMES.109.854877","article-title":"A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program","volume":"3","author":"Peterson","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026080920452718600_EHW128C539","first-page":"572","article-title":"Risk stratification for in-hospital mortality in acutely decompensated heart failure classification and regression tree analysis","volume":"293","author":"Adams","year":"2015","journal-title":"JAMA"},{"key":"2026080920452718600_EHW128C540","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ejhf.289","article-title":"Recommendations on pre-hospital and early hospital management of acute heart failure: a consensus paper from the HFA of the ESC, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine","volume":"17","author":"Mebazaa","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C541","doi-asserted-by":"crossref","first-page":"590","DOI":"10.7326\/0003-4819-152-9-201005040-00009","article-title":"Meta-analysis: noninvasive ventilation in acute cardiogenic pulmonary edema","volume":"152","author":"Weng","year":"2010","journal-title":"Ann Intern Med"},{"key":"2026080920452718600_EHW128C542","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta13330","article-title":"A multicentre randomised controlled trial of the use of continuous positive airway pressure and non-invasive positive pressure ventilation in the early treatment of patients presenting to the emergency department with severe acute cardiogenic pulmonary oedema: the 3CPO Trial","volume":"13","author":"Gray","year":"2009","journal-title":"Health Technol Assess"},{"key":"2026080920452718600_EHW128C543","first-page":"CD005351","article-title":"Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema","volume":"5","author":"Vital","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080920452718600_EHW128C544","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1097\/01.CCM.0000147770.20400.10","article-title":"Randomized, prospective trial of oxygen, continuous positive airway pressure, and bilevel positive airway pressure by face mask in acute cardiogenic pulmonary edema","volume":"32","author":"Park","year":"2004","journal-title":"Crit Care Med"},{"key":"2026080920452718600_EHW128C545","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMoa0707992","article-title":"Noninvasive ventilation in acute cardiogenic pulmonary edema","volume":"359","author":"Gray","year":"2008","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C546","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/bmj.1.6018.1121","article-title":"Controlled trial of oxygen in uncomplicated myocardial infarction","volume":"1","author":"Rawles","year":"1976","journal-title":"Br Med J"},{"key":"2026080920452718600_EHW128C547","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/hrt.2009.175257","article-title":"Potentially detrimental cardiovascular effects of oxygen in patients with chronic left ventricular systolic dysfunction","volume":"96","author":"Park","year":"2010","journal-title":"Heart"},{"key":"2026080920452718600_EHW128C548","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C549","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2010.06.034","article-title":"Combination of loop diuretics with thiazide-type diuretics in heart failure","volume":"56","author":"Jentzer","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C550","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1100171","article-title":"Effect of nesiritide in patients with acute decompensated heart failure","volume":"365","author":"O'Connor","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C551","first-page":"CD005151","article-title":"Nitrates for acute heart failure syndromes","volume":"8","author":"Wakai","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080920452718600_EHW128C552","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00134-010-2073-4","article-title":"Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods","volume":"37","author":"Mebazaa","year":"2011","journal-title":"Intensive Care Med"},{"key":"2026080920452718600_EHW128C553","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0735-1097(00)00785-3","article-title":"High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema","volume":"36","author":"Sharon","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C554","first-page":"1531","article-title":"Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial","volume":"287","author":"Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF)","year":"2002","journal-title":"JAMA"},{"key":"2026080920452718600_EHW128C555","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJM198205133061902","article-title":"Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure: results of a Veterans Administration cooperative study","volume":"306","author":"Cohn","year":"1982","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C556","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ahj.2006.09.005","article-title":"Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure","volume":"153","author":"Elkayam","year":"2007","journal-title":"Am Heart J"},{"key":"2026080920452718600_EHW128C557","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/bja\/aev284","article-title":"The effect of inotropes and vasopressors on mortality: a meta-analysis of randomized clinical trials","volume":"115","author":"Belletti","year":"2015","journal-title":"Br J Anaesth"},{"key":"2026080920452718600_EHW128C558","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C559","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1053\/j.jvca.2015.03.023","article-title":"Levosimendan treatment for heart failure: a systematic review and meta-analysis","volume":"29","author":"Gong","year":"2015","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2026080920452718600_EHW128C560","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/bcpt.12385","article-title":"Milrinone for the treatment of acute heart failure after acute myocardial infarction: a systematic review and meta-analysis","volume":"117","author":"Tang","year":"2015","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2026080920452718600_EHW128C561","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","article-title":"Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial","volume":"287","author":"Cuffe","year":"2002","journal-title":"JAMA"},{"key":"2026080920452718600_EHW128C562","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0002-8703(99)70250-4","article-title":"Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST)","volume":"138","author":"O'Connor","year":"1999","journal-title":"Am Heart J"},{"key":"2026080920452718600_EHW128C563","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s40256-015-0134-3","article-title":"Dobutamine therapy is associated with worse clinical outcomes compared with nesiritide therapy for acute decompensated heart failure: a systematic review and meta-analysis","volume":"15","author":"Wang","year":"2015","journal-title":"Am J Cardiovasc Drugs"},{"key":"2026080920452718600_EHW128C564","doi-asserted-by":"crossref","first-page":"278","DOI":"10.7326\/0003-4819-146-4-200702200-00007","article-title":"Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients","volume":"146","author":"Dentali","year":"2007","journal-title":"Ann Intern Med"},{"key":"2026080920452718600_EHW128C565","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0002-9149(97)00962-4","article-title":"Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias","volume":"81","author":"Clemo","year":"1998","journal-title":"Am J Cardiol"},{"key":"2026080920452718600_EHW128C566","first-page":"521","article-title":"Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone","volume":"16","author":"Hou","year":"1995","journal-title":"A randomized, digoxin-controlled study. Eur Heart J"},{"key":"2026080920452718600_EHW128C567","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/00003246-200106000-00011","article-title":"Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias","volume":"29","author":"Delle Karth","year":"2001","journal-title":"Crit Care Med"},{"key":"2026080920452718600_EHW128C568","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3109\/17482941.2011.575165","article-title":"Use of intravenous morphine for acute decompensated heart failure in patients with and without acute coronary syndromes","volume":"13","author":"Iakobishvili","year":"2011","journal-title":"Acute Card Care"},{"key":"2026080920452718600_EHW128C569","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/emj.2007.050419","article-title":"Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis","volume":"25","author":"Peacock","year":"2008","journal-title":"Emerg Med J"},{"key":"2026080920452718600_EHW128C570","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cardfail.2014.05.007","article-title":"Loop diuretic resistance in heart failure: resistance etiology-based strategies to restoring diuretic efficacy","volume":"20","author":"Cox","year":"2014","journal-title":"J Card Fail"},{"key":"2026080920452718600_EHW128C571","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ejhf.74","article-title":"Decongestion in acute heart failure","volume":"16","author":"Mentz","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C572","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/eurjhf\/hfn045","article-title":"Levosimendan vs. dobutamine: outcomes for acute heart failure patients on \u03b2-blockers in SURVIVE","volume":"11","author":"Mebazaa","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C573","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/jcpt.12067","article-title":"Pharmacology of levosimendan: inotropic, vasodilatory and cardioprotective effects","volume":"38","author":"Pathak","year":"2013","journal-title":"J Clin Pharm Ther"},{"key":"2026080920452718600_EHW128C574","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijcard.2011.07.022","article-title":"Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan","volume":"159","author":"Papp","year":"2012","journal-title":"Int J Cardiol"},{"key":"2026080920452718600_EHW128C575","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ijcard.2008.08.020","article-title":"Levosimendan for the treatment of acute severe heart failure: a meta-analysis of randomised controlled trials","volume":"138","author":"Delaney","year":"2010","journal-title":"Int J Cardiol"},{"key":"2026080920452718600_EHW128C576","first-page":"1","article-title":"European Resuscitation Council Guidelines for Resuscitation 2015: Section 1","volume":"95","author":"Monsieurs","year":"2015","journal-title":"Executive summary. Resuscitation"},{"key":"2026080920452718600_EHW128C577","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","article-title":"Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials","volume":"297","author":"Gheorghiade","year":"2007","journal-title":"JAMA"},{"key":"2026080920452718600_EHW128C578","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in decompensated heart failure with cardiorenal syndrome","volume":"367","author":"Bart","year":"2012","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C579","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jacc.2006.07.073","article-title":"Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure","volume":"49","author":"Costanzo","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C580","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cardfail.2009.12.009","article-title":"Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD","volume":"16","author":"Costanzo","year":"2010","journal-title":"J Card Fail"},{"key":"2026080920452718600_EHW128C581","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.cardfail.2008.02.010","article-title":"Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure","volume":"14","author":"Mullens","year":"2008","journal-title":"J Card Fail"},{"key":"2026080920452718600_EHW128C582","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1097\/CCM.0b013e3181809846","article-title":"Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction","volume":"36","author":"Fuhrmann","year":"2008","journal-title":"Crit Care Med"},{"key":"2026080920452718600_EHW128C583","first-page":"2732","article-title":"Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock","volume":"35","author":"Russ","year":"2007","journal-title":"Crit Care Med"},{"key":"2026080920452718600_EHW128C584","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0735-1097(02)02968-6","article-title":"Heart failure etiology and response tomilrinone in decompensated heart failure","volume":"41","author":"Felker","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C585","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C586","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(13)61783-3","article-title":"Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial","volume":"382","author":"Thiele","year":"2013","journal-title":"Lancet"},{"key":"2026080920452718600_EHW128C587","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jchf.2015.03.008","article-title":"Effects of beta-blocker withdrawal in acute decompensated heart failure: a systematic review and meta-analysis","volume":"3","author":"Prins","year":"2015","journal-title":"JACC Heart Fail"},{"key":"2026080920452718600_EHW128C588","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10741-014-9442-y","article-title":"BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review","volume":"19","author":"Santaguida","year":"2014","journal-title":"Heart Fail Rev"},{"key":"2026080920452718600_EHW128C589","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jchf.2013.11.007","article-title":"Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis","volume":"2","author":"Savarese","year":"2014","journal-title":"JACC Heart Fail"},{"key":"2026080920452718600_EHW128C590","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/eurheartj\/eht466","article-title":"Natriuretic peptides in cardiovascular diseases: current use and perspectives","volume":"35","author":"Volpe","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C591","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/eurjhf\/hfq219","article-title":"Self-care management of heart failure: practical recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of Cardiology","volume":"13","author":"Lainscak","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C592","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/eurjhf\/hfq221","article-title":"European Society of Cardiology Heart Failure Association Standards for delivering heart failure care","volume":"13","author":"McDonagh","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C593","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/CIRCULATIONAHA.111.060830","article-title":"Mechanical circulatory support for advanced heart failure: patients and technology in evolution","volume":"125","author":"Stewart","year":"2012","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C594","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/eurheartj\/ehv194","article-title":"Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score","volume":"36","author":"Schmidt","year":"2015","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C595","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/ejcts\/ezu093","article-title":"Preoperative patient optimization using extracorporeal life support improves outcomes of INTERMACS level I patients receiving a permanent ventricular assist device","volume":"46","author":"Riebandt","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026080920452718600_EHW128C596","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/eurheartj\/ehp292","article-title":"Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials","volume":"30","author":"Cheng","year":"2009","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C597","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1161\/CIRCULATIONAHA.112.098194","article-title":"A prospective, randomized clinical trial of hemodynamic support with impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study","volume":"126","author":"O'Neill","year":"2012","journal-title":"Circulation"},{"key":"2026080920452718600_EHW128C598","article-title":"Eurotransplant International Foundation Annual Report 2013","author":"Rahmel","year":"2013"},{"key":"2026080920452718600_EHW128C599","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.athoracsur.2014.05.019","article-title":"Survival on the heart transplant waiting list: impact of continuous flow left ventricular assist device as bridge to transplant","volume":"98","author":"Trivedi","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"2026080920452718600_EHW128C600","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMoa067758","article-title":"Use of a continuous-flow device in patients awaiting heart transplantation","volume":"357","author":"Miller","year":"2007","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C601","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.healun.2014.04.010","article-title":"Sixth INTERMACS annual report: a 10,000-patient database","volume":"33","author":"Kirklin","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"2026080920452718600_EHW128C602","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jtcvs.2012.08.048","article-title":"Cardiac transplant or rotary blood pump: contemporary evidence","volume":"145","author":"Westaby","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026080920452718600_EHW128C603","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jchf.2015.05.011","article-title":"The HVAD left ventricular assist device: risk factors for neurological events and risk mitigation strategies","volume":"3","author":"Teuteberg","year":"2015","journal-title":"JACC Heart Fail"},{"key":"2026080920452718600_EHW128C604","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.healun.2015.10.003","article-title":"Seventh INTERMACS annual report: 15,000 patients and counting","volume":"34","author":"Kirklin","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"2026080920452718600_EHW128C605","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jacc.2015.07.075","article-title":"Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: results from the ROADMAP study","volume":"66","author":"Estep","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C606","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jchf.2015.09.007","article-title":"Development of a decision aid for patients with advanced heart failure considering a destination therapy left ventricular assist device","volume":"3","author":"Thompson","year":"2015","journal-title":"JACC Heart Fail"},{"key":"2026080920452718600_EHW128C607","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ijnurstu.2011.11.002","article-title":"Effectiveness of heart failure management programmes with nurse-led discharge planning in reducing re-admissions: a systematic review and meta-analysis","volume":"49","author":"Lambrinou","year":"2012","journal-title":"Int J Nurs Stud"},{"key":"2026080920452718600_EHW128C608","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1056\/NEJMoa053063","article-title":"Left ventricular assist device and drug therapy for the reversal of heart failure","volume":"355","author":"Birks","year":"2006","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C609","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ejhf.18","article-title":"Contribution of ventricular assist devices to the recovery of failing hearts: a review and the Berlin Heart Center Experience","volume":"16","author":"Dandel","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C610","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.jacc.2014.01.053","article-title":"Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support)","volume":"63","author":"Jorde","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C611","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1751-7133.2011.00236.x","article-title":"Patient selection for left ventricular assist devices","volume":"17","author":"Khazanie","year":"2011","journal-title":"Congest Heart Fail"},{"key":"2026080920452718600_EHW128C612","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa012175","article-title":"Long-term use of a left ventricular assist device for end-stage heart failure","volume":"345","author":"Rose","year":"2001","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C613","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa0909938","article-title":"Advanced heart failure treated with continuous-flow left ventricular assist device","volume":"361","author":"Slaughter","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C614","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1136\/heartjnl-2011-300048","article-title":"UK guidelines for referral and assessment of adults for heart transplantation","volume":"97","author":"Banner","year":"2011","journal-title":"Heart"},{"key":"2026080920452718600_EHW128C615","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.healun.2006.06.008","article-title":"Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates\u20142006","volume":"25","author":"Mehra","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"2026080920452718600_EHW128C616","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2015.10.023","article-title":"The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update","volume":"35","author":"Mehra","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"2026080920452718600_EHW128C617","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/ejhf.41","article-title":"Heart failure association of the European Society of Cardiology specialist heart failure curriculum","volume":"16","author":"McDonagh","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C618","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.2009.454","article-title":"Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial","volume":"301","author":"O'Connor","year":"2009","journal-title":"JAMA"},{"key":"2026080920452718600_EHW128C619","first-page":"CD003331","article-title":"Exercise-based rehabilitation for heart failure","volume":"4","author":"Taylor","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080920452718600_EHW128C620","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1177\/2047487314526071","article-title":"Effects of exercise training on different quality of life dimensions in heart failure with preserved ejection fraction: the Ex-DHF-P trial","volume":"22","author":"Nolte","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"2026080920452718600_EHW128C621","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jchf.2013.08.006","article-title":"Clinical outcomes and cardiovascular responses to different exercise training intensities in patients with heart failure: a systematic review and meta-analysis","volume":"1","author":"Ismail","year":"2013","journal-title":"JACC Heart Fail"},{"key":"2026080920452718600_EHW128C622","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jama.291.11.1358","article-title":"Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: a meta-analysis","volume":"291","author":"Phillips","year":"2004","journal-title":"JAMA"},{"key":"2026080920452718600_EHW128C623","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1001\/archinte.159.3.257","article-title":"Prolonged beneficial effects of a home-based intervention on unplanned readmissions and mortality among patients with congestive heart failure","volume":"159","author":"Stewart","year":"1999","journal-title":"Arch Intern Med"},{"key":"2026080920452718600_EHW128C624","first-page":"810","article-title":"Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials","volume":"44","author":"McAlister","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C625","doi-asserted-by":"crossref","first-page":"774","DOI":"10.7326\/M14-0083","article-title":"Transitional care interventions to prevent readmissions for persons with heart failure: a systematic review and meta-analysis","volume":"160","author":"Feltner","year":"2014","journal-title":"Ann Intern Med"},{"key":"2026080920452718600_EHW128C626","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/eurheartj\/ehs235","article-title":"Extended heart failure clinic follow-up in low-risk patients: a randomized clinical trial (NorthStar)","volume":"34","author":"Schou","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C627","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/ejhf.173","article-title":"Long-term follow-up in optimally treated and stable heart failure patients: primary care vs. heart failure clinic. Results of the COACH-2 study","volume":"16","author":"Luttik","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C628","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","article-title":"Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial","volume":"377","author":"Abraham","year":"2011","journal-title":"Lancet"},{"key":"2026080920452718600_EHW128C629","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(15)00723-0","article-title":"Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial","volume":"387","author":"Abraham","year":"2016","journal-title":"Lancet"},{"key":"2026080920452718600_EHW128C630","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(14)61176-4","article-title":"Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial","volume":"384","author":"Hindricks","year":"2014","journal-title":"Lancet"},{"key":"2026080920452718600_EHW128C631","article-title":"European Society of Cardiology-Acute Cardiovascular Care Association position paper on acute heart failure: a call for interdisciplinary care","author":"Mueller","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026080920452718600_EHW128C632","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s11606-014-3105-5","article-title":"Hospital strategy uptake and reductions in unplanned readmission rates for patients with heart failure: a prospective study","volume":"30","author":"Bradley","year":"2015","journal-title":"J Gen Intern Med"},{"key":"2026080920452718600_EHW128C633","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/eurjhf\/hfs048","article-title":"Adherence of heart failure patients to exercise: barriers and possible solutions: a position statement of the Study Group on Exercise Training in Heart Failure of the Heart Failure Association of the European Society of Cardiology","volume":"14","author":"Conraads","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C634","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jacc.2013.04.033","article-title":"Effect of endurance exercise training on endothelial function and arterial stiffness in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial","volume":"62","author":"Kitzman","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026080920452718600_EHW128C635","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10741-014-9451-x","article-title":"B-type natriuretic peptide-guided therapy: a systematic review","volume":"19","author":"Balion","year":"2014","journal-title":"Heart Fail Rev"},{"key":"2026080920452718600_EHW128C636","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/eurheartj\/ehu090","article-title":"Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis","volume":"35","author":"Troughton","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C637","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2459\/JCM.0b013e328364bde1","article-title":"B-type natriuretic peptide-guided versus symptom-guided therapy in outpatients with chronic heart failure: a systematic review with meta-analysis","volume":"15","author":"De Vecchis","year":"2014","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2026080920452718600_EHW128C638","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/eurheartj\/eht463","article-title":"Natriuretic peptide-guided heart failure management","volume":"35","author":"Troughton","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080920452718600_EHW128C639","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0140-6736(11)61229-4","article-title":"Telemedicine and remote management of patients with heart failure","volume":"378","author":"Anker","year":"2011","journal-title":"Lancet"},{"key":"2026080920452718600_EHW128C640","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1056\/NEJMoa1010029","article-title":"Telemonitoring in patients with heart failure","volume":"363","author":"Chaudhry","year":"2010","journal-title":"N Engl J Med"},{"key":"2026080920452718600_EHW128C641","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/eurjhf\/hfq199","article-title":"Telemedical Interventional Monitoring in Heart Failure (TIM-HF), a randomized, controlled intervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: study design","volume":"12","author":"Koehler","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C642","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCHEARTFAILURE.111.962969","article-title":"Mode of action and effects of standardized collaborative disease management on mortality and mobidity in patient with systolic heart failure","volume":"5","author":"Angermann","year":"2012","journal-title":"Circ Heart Fail"},{"key":"2026080920452718600_EHW128C643","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/eurjhf\/hfs023","article-title":"Weight monitoring in patients with severe heart failure (WISH). A randomized controlled trial","volume":"14","author":"Lyng","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C644","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/eurjhf\/hfs058","article-title":"Tailored telemonitoring in patients with heart failure: results of a multicentre randomized controlled trial","volume":"14","author":"Boyne","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C645","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/clc.22345","article-title":"FRAIL-HF, a study to evaluate the clinical complexity of heart failure in nondependent older patients: rationale, methods and baseline characteristics","volume":"37","author":"Vid\u00e1n","year":"2014","journal-title":"Clin Cardiol"},{"key":"2026080920452718600_EHW128C646","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/ageing\/afu138","article-title":"Best practice guidelines for the management of frailty: a British Geriatrics Society, Age UK and Royal College of General Practitioners report","volume":"43","author":"Turner","year":"2014","journal-title":"Age Ageing"},{"key":"2026080920452718600_EHW128C647","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1532-5415.2012.04074.x","article-title":"Comparison of frailty indicators based on clinical phenotype and the multiple deficit approach in predicting mortality and physical limitation","volume":"60","author":"Woo","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"2026080920452718600_EHW128C648","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2026080920452718600_EHW128C649","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"2026080920452718600_EHW128C650","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"2026080920452718600_EHW128C651","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13195-015-0106-5","article-title":"\u2018Hearts and minds\u2019: association, causation and implication of cognitive impairment in heart failure","volume":"7","author":"Cannon","year":"2015","journal-title":"Alzheimers Res Ther"},{"key":"2026080920452718600_EHW128C652","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1136\/heartjnl-2014-306724","article-title":"Future care planning: a first step to palliative care for all patients with advanced heart disease","volume":"101","author":"Denvir","year":"2015","journal-title":"Heart"},{"key":"2026080920452718600_EHW128C653","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cardfail.2012.10.019","article-title":"Examining the effects of an outpatient palliative care consultation on symptom burden, depression, and quality of life in patients with symptomatic heart failure","volume":"18","author":"Evangelista","year":"2012","journal-title":"J Card Fail"},{"key":"2026080920452718600_EHW128C654","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/eurjhf\/hfp041","article-title":"Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology","volume":"11","author":"Jaarsma","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C655","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/ejhf.151","article-title":"Effects of person-centred and integrated chronic heart failure and palliative home care. PREFER: a randomized controlled study","volume":"16","author":"Br\u00e4nnstr\u00f6m","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C656","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1388-9842(02)00158-7","article-title":"Morphine for the relief of breathlessness in patients with chronic heart failure\u2014a pilot study","volume":"4","author":"Johnson","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"2026080920452718600_EHW128C657","author":"Palliative Care Outcome Scale (POS)"},{"key":"2026080920452718600_EHW128C658","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jpainsymman.2013.05.006","article-title":"The relationship between two performance scales: New York Heart Association Classification and Karnofsky Performance Status Scale","volume":"47","author":"Johnson","year":"2014","journal-title":"J Pain Symptom Manage"},{"key":"2026080920452718600_EHW128C659","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpainsymman.2007.12.015","article-title":"Reliability and validity of the Functional Assessment of Chronic Illness Therapy-Palliative care (FACIT-Pal) scale","volume":"37","author":"Lyons","year":"2009","journal-title":"J Pain Symptom Manage"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/37\/27\/2129\/70580139\/eurheartj_37_27_2129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/37\/27\/2129\/70580139\/eurheartj_37_27_2129.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:46:58Z","timestamp":1786322818000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/37\/27\/2129\/1748921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,20]]},"references-count":659,"journal-issue":{"issue":"27","published-online":{"date-parts":[[2016,5,20]]},"published-print":{"date-parts":[[2016,7,14]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehw128","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,7,14]]},"published":{"date-parts":[[2016,5,20]]}}}